AB 1697: Uniform Electronic Transactions Act.
- Session Year: 2023-2024
- House: Assembly
- Latest Version Date: 2023-10-07
Current Status:
Passed
(2023-10-07: Chaptered by Secretary of State - Chapter 374, Statutes of 2023.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Enacted
Existing law, the Uniform Electronic Transactions Act, provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form. The act exempts from its provisions, among other things, specific transactions, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan under the Confidentiality of Medical Information Act.
This bill would delete the exemption for the above-described authorizations under the Confidentiality of Medical Information Act and would make conforming changes.
Existing law requires that the authorization for release of medical information contain a specific end date.
This bill would, instead, require that the authorization contain an expiration date or event, as defined, and would limit the duration of the authorization to one year or less, except as provided. The bill would also require that the person to whom the medical information pertains receives a copy of the authorization for that authorization to be valid.
This bill would incorporate additional changes to Section 56.05 of the Civil Code proposed by AB 254 to be operative only if this bill and AB 254 are enacted and this bill is enacted last.
Existing law, the Uniform Electronic Transactions Act, provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form. The act exempts from its provisions, among other things, specific transactions, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan under the Confidentiality of Medical Information Act.
This bill would delete the exemption for the above-described authorizations under the Confidentiality of Medical Information Act and would make conforming changes.
Existing law requires that the authorization for release of medical information contain a specific end date.
This bill would, instead, require that the authorization contain an expiration date or event, as defined, and would limit the duration of the authorization to one year or less, except as provided. The bill would also require that the person to whom the medical information pertains receives a copy of the authorization for that authorization to be valid.
This bill would incorporate additional changes to Section 56.05 of the Civil Code proposed by AB 254 to be operative only if this bill and AB 254 are enacted and this bill is enacted last.
Existing law, the Uniform Electronic Transactions Act, provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form. The act exempts from its provisions, among other things, specific transactions, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan under the Confidentiality of Medical Information Act.
This bill would delete the exemption for the above-described authorizations under the Confidentiality of Medical Information Act and would make conforming changes.
Existing law requires that the authorization for release of medical information contain a specific end date.
This bill would, instead, require that the authorization contain an expiration date or event, as defined, and would limit the duration of the authorization to one year or less, except as provided. The bill would also require that the person to whom the medical information pertains receives a copy of the authorization for that authorization to be valid.
This bill would incorporate additional changes to Section 56.05 of the Civil Code proposed by AB 254 to be operative only if this bill and AB 254 are enacted and this bill is enacted last.
Existing law, the Uniform Electronic Transactions Act, provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form. The act exempts from its provisions, among other things, specific transactions, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan under the Confidentiality of Medical Information Act.
This bill would delete the exemption for the above-described authorizations under the Confidentiality of Medical Information Act and would make conforming changes.
Existing law requires that the authorization for release of medical information contain a specific end date.
This bill would, instead, require that the authorization contain a specific end date or expiration event, as specified. an expiration date or event, as defined, and would limit the duration of the authorization to one year or less, except as provided. The bill would also require that the person to whom the medical information pertains receives a copy of the authorization for that authorization to be valid.
Existing law, the Uniform Electronic Transactions Act, provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form. The act exempts from its provisions, among other things, specific transactions, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan under the Confidentiality of Medical Information Act.
This bill would delete the exemption for the above-described authorizations under the Confidentiality of Medical Information Act and would make conforming changes.
Existing law requires that the authorization for release of medical information contain a specific end date.
This bill would, instead, require that the authorization contain a specific end date or expiration event. event, as specified.
Existing law, the Uniform Electronic Transactions Act, provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form. The act exempts from its provisions, among other things, specific transactions, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan under the Confidentiality of Medical Information Act.
This bill would delete the exemption for the above-described authorizations under the Confidentiality of Medical Information Act and would make conforming changes.
Existing law requires that the authorization for release of medical information contain a specific end date.
This bill would, instead, require that the authorization contain a specific end date or expiration event.
Existing law, the Uniform Electronic Transactions Act, provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form. The act exempts from its provisions, among other things, specific transactions, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan under the Confidentiality of Medical Information Act.
This bill would delete the exemption for the above-described authorizations under the Confidentiality of Medical Information Act. Act and would make conforming changes.
Existing law, the Uniform Electronic Transactions Act, provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form. The act exempts from its provisions, among other things, specific transactions, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan under the Confidentiality of Medical Information Act.
This bill would delete the exemption for the above-described authorizations under the Confidentiality of Medical Information Act.
For purposes of this part:
(a)Authorization means permission granted in accordance with Section 56.11 or 56.21 for the disclosure of medical information.
(b)Authorized recipient means a person who is authorized to receive medical information pursuant to Section 56.10 or 56.20.
(c)Confidential communications request means a request by a subscriber or enrollee that health care service plan communications containing medical information be communicated to them at a specific mail or email address or specific telephone number, as designated by the subscriber or enrollee.
(d)Contractor means a person or entity that is a medical group, independent practice association, pharmaceutical benefits manager, or a medical service organization and is not a health care service plan or provider of health care. Contractor does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code or pharmaceutical benefits managers licensed pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(e)Enrollee has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
(f)Expiration date or event means a specified date or an occurrence relating to the individual to whom the medical information pertains or the purpose of the use or disclosure, after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(g)Health care service plan means an entity regulated pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(h)Licensed health care professional means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code, the Osteopathic Initiative Act or the Chiropractic Initiative Act, or Division 2.5 (commencing with Section 1797) of the Health and Safety Code.
(i)Marketing means to make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service.
Marketing does not include any of the following:
(1)Communications made orally or in writing for which the communicator does not receive direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication.
(2)Communications made to current enrollees solely for the purpose of describing a providers participation in an existing health care provider network or health plan network of a Knox-Keene licensed health plan to which the enrollees already subscribe; communications made to current enrollees solely for the purpose of describing if, and the extent to which, a product or service, or payment for a product or service, is provided by a provider, contractor, or plan or included in a plan of benefits of a Knox-Keene licensed health plan to which the enrollees already subscribe; or communications made to plan enrollees describing the availability of more cost-effective pharmaceuticals.
(3)Communications that are tailored to the circumstances of a particular individual to educate or advise the individual about treatment options, and otherwise maintain the individuals adherence to a prescribed course of medical treatment, as provided in Section 1399.901 of the Health and Safety Code, for a chronic and seriously debilitating or life-threatening condition as defined in subdivisions (d) and (e) of Section 1367.21 of the Health and Safety Code, if the health care provider, contractor, or health plan receives direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication, if all of the following apply:
(A)The individual receiving the communication is notified in the communication in typeface no smaller than 14-point type of the fact that the provider, contractor, or health plan has been remunerated and the source of the remuneration.
(B)The individual is provided the opportunity to opt out of receiving future remunerated communications.
(C)The communication contains instructions in typeface no smaller than 14-point type describing how the individual can opt out of receiving further communications by calling a toll-free number of the health care provider, contractor, or health plan making the remunerated communications. Further communication shall not be made to an individual who has opted out after 30 calendar days from the date the individual makes the opt-out request.
(j)Medical information means any individually identifiable information, in electronic or physical form, in possession of or derived from a provider of health care, health care service plan, pharmaceutical company, or contractor regarding a patients medical history, mental health application information, mental or physical condition, or treatment. Individually identifiable means that the medical information includes or contains any element of personal identifying information sufficient to allow identification of the individual, such as the patients name, address, electronic mail address, telephone number, or social security number, or other information that, alone or in combination with other publicly available information, reveals the identity of the individual.
(k)Mental health application information means information related to a consumers inferred or diagnosed mental health or substance use disorder, as defined in Section 1374.72 of the Health and Safety Code, collected by a mental health digital service.
(l)Mental health digital service means a mobile-based application or internet website that collects mental health application information from a consumer, markets itself as facilitating mental health services to a consumer, and uses the information to facilitate mental health services to a consumer.
(m)Patient means a natural person, whether or not still living, who received health care services from a provider of health care and to whom medical information pertains.
(n)Pharmaceutical company means a company or business, or an agent or representative thereof, that manufactures, sells, or distributes pharmaceuticals, medications, or prescription drugs. Pharmaceutical company does not include a pharmaceutical benefits manager, as included in subdivision (c), or a provider of health care.
(o)Protected individual means any adult covered by the subscribers health care service plan or a minor who can consent to a health care service without the consent of a parent or legal guardian, pursuant to state or federal law. Protected individual does not include an individual that lacks the capacity to give informed consent for health care pursuant to Section 813 of the Probate Code.
(p)Provider of health care means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code; a person licensed pursuant to the Osteopathic Initiative Act or the Chiropractic Initiative Act; a person certified pursuant to Division 2.5 (commencing with Section 1797) of the Health and Safety Code; or a clinic, health dispensary, or health facility licensed pursuant to Division 2 (commencing with Section 1200) of the Health and Safety Code. Provider of health care does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code.
(q)Sensitive services means all health care services related to mental or behavioral health, sexual and reproductive health, sexually transmitted infections, substance use disorder, gender affirming care, and intimate partner violence, and includes services described in Sections 6924, 6925, 6926, 6927, 6928, 6929, and 6930 of the Family Code, and Sections 121020 and 124260 of the Health and Safety Code, obtained by a patient at or above the minimum age specified for consenting to the service specified in the section.
(r)Subscriber has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
SEC. 1.5.Section 56.05 of the Civil Code is amended to read:56.05.For purposes of this part:
(a)Authorization means permission granted in accordance with Section 56.11 or 56.21 for the disclosure of medical information.
(b)Authorized recipient means a person who is authorized to receive medical information pursuant to Section 56.10 or 56.20.
(c)Confidential communications request means a request by a subscriber or enrollee that health care service plan communications containing medical information be communicated to them at a specific mail or email address or specific telephone number, as designated by the subscriber or enrollee.
(d)Contractor means a person or entity that is a medical group, independent practice association, pharmaceutical benefits manager, or a medical service organization and is not a health care service plan or provider of health care. Contractor does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code or pharmaceutical benefits managers licensed pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(e)Enrollee has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
(f)Expiration date or event means a specified date or an occurrence relating to the individual to whom the medical information pertains or the purpose of the use or disclosure, after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(g)Health care service plan means an entity regulated pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(h)Licensed health care professional means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code, the Osteopathic Initiative Act or the Chiropractic Initiative Act, or Division 2.5 (commencing with Section 1797) of the Health and Safety Code.
(i)Marketing means to make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service.
Marketing does not include any of the following:
(1)Communications made orally or in writing for which the communicator does not receive direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication.
(2)Communications made to current enrollees solely for the purpose of describing a providers participation in an existing health care provider network or health plan network of a Knox-Keene licensed health plan to which the enrollees already subscribe; communications made to current enrollees solely for the purpose of describing if, and the extent to which, a product or service, or payment for a product or service, is provided by a provider, contractor, or plan or included in a plan of benefits of a Knox-Keene licensed health plan to which the enrollees already subscribe; or communications made to plan enrollees describing the availability of more cost-effective pharmaceuticals.
(3)Communications that are tailored to the circumstances of a particular individual to educate or advise the individual about treatment options, and otherwise maintain the individuals adherence to a prescribed course of medical treatment, as provided in Section 1399.901 of the Health and Safety Code, for a chronic and seriously debilitating or life-threatening condition as defined in subdivisions (d) and (e) of Section 1367.21 of the Health and Safety Code, if the health care provider, contractor, or health plan receives direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication, if all of the following apply:
(A)The individual receiving the communication is notified in the communication in typeface no smaller than 14-point type of the fact that the provider, contractor, or health plan has been remunerated and the source of the remuneration.
(B)The individual is provided the opportunity to opt out of receiving future remunerated communications.
(C)The communication contains instructions in typeface no smaller than 14-point type describing how the individual can opt out of receiving further communications by calling a toll-free number of the health care provider, contractor, or health plan making the remunerated communications. Further communication shall not be made to an individual who has opted out after 30 calendar days from the date the individual makes the opt-out request.
(j)Medical information means any individually identifiable information, in electronic or physical form, in possession of or derived from a provider of health care, health care service plan, pharmaceutical company, or contractor regarding a patients medical history, mental health application information, reproductive or sexual health application information, mental or physical condition, or treatment. Individually identifiable means that the medical information includes or contains any element of personal identifying information sufficient to allow identification of the individual, such as the patients name, address, electronic mail address, telephone number, or social security number, or other information that, alone or in combination with other publicly available information, reveals the identity of the individual.
(k)Mental health application information means information related to a consumers inferred or diagnosed mental health or substance use disorder, as defined in Section 1374.72 of the Health and Safety Code, collected by a mental health digital service.
(l)Mental health digital service means a mobile-based application or internet website that collects mental health application information from a consumer, markets itself as facilitating mental health services to a consumer, and uses the information to facilitate mental health services to a consumer.
(m)Patient means a natural person, whether or not still living, who received health care services from a provider of health care and to whom medical information pertains.
(n)Pharmaceutical company means a company or business, or an agent or representative thereof, that manufactures, sells, or distributes pharmaceuticals, medications, or prescription drugs. Pharmaceutical company does not include a pharmaceutical benefits manager, as included in subdivision (c), or a provider of health care.
(o)Protected individual means any adult covered by the subscribers health care service plan or a minor who can consent to a health care service without the consent of a parent or legal guardian, pursuant to state or federal law. Protected individual does not include an individual that lacks the capacity to give informed consent for health care pursuant to Section 813 of the Probate Code.
(p)Provider of health care means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code; a person licensed pursuant to the Osteopathic Initiative Act or the Chiropractic Initiative Act; a person certified pursuant to Division 2.5 (commencing with Section 1797) of the Health and Safety Code; or a clinic, health dispensary, or health facility licensed pursuant to Division 2 (commencing with Section 1200) of the Health and Safety Code. Provider of health care does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code.
(q)Reproductive or sexual health application information means information about a consumers reproductive health, menstrual cycle, fertility, pregnancy, pregnancy outcome, plans to conceive, or type of sexual activity collected by a reproductive or sexual health digital service, including, but not limited to, information from which one can infer someones pregnancy status, menstrual cycle, fertility, hormone levels, birth control use, sexual activity, or gender identity.
(r)Reproductive or sexual health digital service means a mobile-based application or internet website that collects reproductive or sexual health application information from a consumer, markets itself as facilitating reproductive or sexual health services to a consumer, and uses the information to facilitate reproductive or sexual health services to a consumer.
(s)Sensitive services means all health care services related to mental or behavioral health, sexual and reproductive health, sexually transmitted infections, substance use disorder, gender affirming care, and intimate partner violence, and includes services described in Sections 6924, 6925, 6926, 6927, 6928, 6929, and 6930 of the Family Code, and Sections 121020 and 124260 of the Health and Safety Code, obtained by a patient at or above the minimum age specified for consenting to the service specified in the section.
(t)Subscriber has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
SEC. 2.Section 56.11 of the Civil Code is amended to read:56.11.(a)Any person or entity that wishes to obtain medical information pursuant to subdivision (a) of Section 56.10, other than a person or entity authorized to receive medical information pursuant to subdivision (b) or (c) of Section 56.10, except as provided in paragraph (21) of subdivision (c) of Section 56.10, shall obtain a valid authorization for the release of this information.
(b)An authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor shall be valid if it meets the following conditions:
(1)Is handwritten or is in a typeface no smaller than 14-point type.
(2)Is clearly separate from any other language present on the same page and is executed by a signature that serves no other purpose than to execute the authorization.
(3)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(A)The patient. A patient who is a minor may only sign an authorization for the release of medical information obtained by a provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which the minor could lawfully have consented under Part 4 (commencing with Section 6900) of Division 11 of the Family Code.
(B)The legal representative of the patient, if the patient is a minor or lacks the capacity to make the decision to authorize the release of medical information. However, authorization may not be given under this subdivision for the disclosure of medical information obtained by the provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which a minor patient could lawfully have consented under Part 4 (commencing with Section 6900) of Division 11 of the Family Code.
(C)The spouse of the patient or the person financially responsible for the patient, where the medical information is being sought for the sole purpose of processing an application for health insurance or for enrollment in a nonprofit hospital plan, a health care service plan, or an employee benefit plan, and where the patient is to be an enrolled spouse or dependent under the policy or plan.
(D)The beneficiary, as defined in Section 24 of the Probate Code, or personal representative, as defined in Section 58 of the Probate Code, of a deceased patient.
(4)States the specific uses and limitations on the types of medical information to be disclosed.
(5)States the name or functions of the provider of health care, health care service plan, pharmaceutical company, or contractor that may disclose the medical information.
(6)States the name or functions of the persons or entities authorized to receive the medical information.
(7)States the specific uses and limitations on the use of the medical information by the persons or entities authorized to receive the medical information.
(8)States an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(9)Advises the person signing the authorization of the right to receive a copy of the authorization.
(c)If a provider of health care, health care service plan, pharmaceutical company, contractor, or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the provider of health care, health care service plan, pharmaceutical company, contractor, or other entity shall provide the individual with a copy of the signed authorization, and instructions on how to access additional copies or a digital version of the signed authorization.
SEC. 3.Section 56.17 of the Civil Code is amended to read:56.17.(a)This section shall apply to the disclosure of genetic test results by a health care service plan that are contained in an applicants or enrollees medical records.
(b)Any person who negligently discloses results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not to exceed one thousand dollars ($1,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(c)Any person who willfully discloses the results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not less than one thousand dollars ($1,000) and no more than five thousand dollars ($5,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(d)Any person who willfully or negligently discloses the results of a test for a genetic characteristic to a third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), that results in economic, bodily, or emotional harm to the subject of the test, is guilty of a misdemeanor punishable by a fine not to exceed ten thousand dollars ($10,000).
(e)In addition to the penalties listed in subdivisions (b) and (c), any person who commits any act described in subdivision (b) or (c) shall be liable to the subject for all actual damages, including damages for economic, bodily, or emotional harm which is proximately caused by the act.
(f)Each disclosure made in violation of this section is a separate and actionable offense.
(g)The applicants written authorization, as used in this section, shall satisfy the following requirements:
(1)Is written in plain language and is in a typeface no smaller than 14-point type.
(2)Is dated and signed, including with an electronic or handwritten signature, by the individual or a person authorized to act on behalf of the individual.
(3)Specifies the types of persons authorized to disclose information about the individual.
(4)Specifies the nature of the information authorized to be disclosed.
(5)States the name or functions of the persons or entities authorized to receive the information.
(6)Specifies the purposes for which the information is collected.
(7)Specifies the length of time the authorization shall remain valid or states an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(8)Advises the person signing the authorization of the right to receive a copy of the authorization. Written authorization is required for each separate disclosure of the test results.
(h)If a provider of health care, health care service plan, pharmaceutical company, contractor, or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the provider of health care, health care service plan, pharmaceutical company, contractor, or other entity shall provide the individual with a copy of the signed authorization and instructions on how to access additional copies or a digital version of the signed authorization.
(i)This section shall not apply to disclosures required by the State Department of Health Care Services necessary to monitor compliance with Chapter 1 (commencing with Section 124975) of Part 5 of Division 106 of the Health and Safety Code, nor to disclosures required by the Department of Managed Health Care necessary to administer and enforce compliance with Section 1374.7 of the Health and Safety Code.
(j)For purposes of this section, genetic characteristic has the same meaning as that set forth in subdivision (d) of Section 1374.7 of the Health and Safety Code.
SEC. 4.Section 56.21 of the Civil Code is amended to read:56.21.An authorization for an employer to disclose medical information shall be valid if the authorization complies with all of the following:
(a)Is handwritten or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization.
(c)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)The patient, except that a patient who is a minor may only sign an authorization for the disclosure of medical information obtained by a provider of health care in the course of furnishing services to which the minor could lawfully have consented under Part 4 (commencing with Section 6900) of Division 11 of the Family Code.
(2)The legal representative of the patient, if the patient is a minor or lacks the capacity to make the decision to authorize the release of medical information. However, authorization may not be given under this subdivision for the disclosure of medical information that pertains to a competent minor and that was created by a provider of health care in the course of furnishing services to which a minor patient could lawfully have consented under Part 4 (commencing with Section 6900) of Division 11 of the Family Code.
(3)The beneficiary, as defined in Section 24 of the Probate Code, or personal representative, as defined in Section 58 of the Probate Code, of a deceased patient.
(d)States the limitations, if any, on the types of medical information to be disclosed.
(e)States the name or functions of the employer or person authorized to disclose the medical information.
(f)States the names or functions of the persons or entities authorized to receive the medical information.
(g)States the limitations, if any, on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(i)Advises the person who signed the authorization of the right to receive a copy of the authorization.
(j)If an employer or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the employer or other entity shall provide the individual with a copy of the signed authorization and instructions on how to access additional copies or a digital version of the signed authorization.
SEC. 5.Section 1633.3 of the Civil Code is amended to read:1633.3.(a)Except as otherwise provided in subdivisions (b) and (c), this title applies to electronic records and electronic signatures relating to a transaction.
(b)This title does not apply to transactions subject to any of the following laws:
(1)A law governing the creation and execution of wills, codicils, or testamentary trusts.
(2)Division 1 (commencing with Section 1101) of the Uniform Commercial Code, except Sections 1206 and 1306.
(3)Divisions 3 (commencing with Section 3101), 4 (commencing with Section 4101), 5 (commencing with Section 5101), 8 (commencing with Section 8101), 9 (commencing with Section 9101), and 11 (commencing with Section 11101) of the Uniform Commercial Code.
(4)A law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed, including initialed, from the record. However, this paragraph does not apply to Section 1677 or 1678 of this code or Section 1298 of the Code of Civil Procedure.
(c)This title does not apply to any specific transaction described in Section 17511.5 of the Business and Professions Code, Section 798.14, 1133, or 1134 of, Section 1689.6, 1689.7, or 1689.13 of, Chapter 2.5 (commencing with Section 1695) of Title 5 of Part 2 of Division 3 of, Section 1720, 1785.15, 1789.14, 1789.16, or 1793.23 of, Chapter 1 (commencing with Section 1801) of Title 2 of Part 4 of Division 3 of, Section 1861.24, 1862.5, 1917.712, 1917.713, 1950.6, 1983, 2924b, 2924c, 2924f, 2924i, 2924j, 2924.3, or 2937 of, Article 1.5 (commencing with Section 2945) of Chapter 2 of Title 14 of Part 4 of Division 3 of, Section 2954.5 or 2963 of, Chapter 2b (commencing with Section 2981) or 2d (commencing with Section 2985.7) of Title 14 of Part 4 of Division 3 of, Section 3071.5 of, Part 5 (commencing with Section 4000) of Division 4 of, or Part 5.3 (commencing with Section 6500) of Division 4 of, this code, subdivision (b) of Section 18608 or Section 22328 of the Financial Code, Section 1358.15, 1365, 1368.01, 1368.1, 1371, or 18035.5 of the Health and Safety Code, Section 786 as it applies to individual and group disability policies, 10199.44, 10199.46, 10235.16, 10235.40, 11624.09, or 11624.1 of the Insurance Code, Section 779.1, 10010.1, or 16482 of the Public Utilities Code, or Section 9975 or 11738 of the Vehicle Code. An electronic record may not be substituted for any notice that is required to be sent pursuant to Section 1162 of the Code of Civil Procedure. This subdivision does not prohibit the recordation of any document with a county recorder by electronic means.
(d)This title applies to an electronic record or electronic signature otherwise excluded from the application of this title under subdivision (b) when used for a transaction subject to a law other than those specified in subdivision (b).
(e)A transaction subject to this title is also subject to other applicable substantive law.
(f)The exclusion of a transaction from the application of this title under subdivision (b) or (c) shall be construed only to exclude the transaction from the application of this title, but shall not be construed to prohibit the transaction from being conducted by electronic means if the transaction may be conducted by electronic means under any other applicable law.
(g)Notwithstanding subdivisions (b) and (c), this title shall apply to electronic records and electronic signatures relating to transactions conducted by a person licensed, certified, or registered pursuant to the Alarm Company Act (Chapter 11.6 (commencing with Section 7590) of Division 3 of the Business and Professions Code) for purposes of activities authorized by Section 7599.54 of the Business and Professions Code.
SEC. 6.Section 1.5 of this bill incorporates amendments to Section 56.05 of the Civil Code proposed by both this bill and Assembly Bill 254. That section of this bill shall only become operative if (1) both bills are enacted and become effective on or before January 1, 2024, (2) each bill amends Section 56.05 of the Civil Code, and (3) this bill is enacted after Assembly Bill 254, in which case Section 1 of this bill shall not become operative.
For purposes of this part:
(a)Authorization means permission granted in accordance with Section 56.11 or 56.21 for the disclosure of medical information.
(b)Authorized recipient means a person who is authorized to receive medical information pursuant to Section 56.10 or 56.20.
(c)Confidential communications request means a request by a subscriber or enrollee that health care service plan communications containing medical information be communicated to them at a specific mail or email address or specific telephone number, as designated by the subscriber or enrollee.
(d)Contractor means a person or entity that is a medical group, independent practice association, pharmaceutical benefits manager, or a medical service organization and is not a health care service plan or provider of health care. Contractor does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code or pharmaceutical benefits managers licensed pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(e)Enrollee has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
(f)Expiration date or event means a specified date or an occurrence relating to the individual to whom the medical information pertains or the purpose of the use or disclosure, after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(g)Health care service plan means an entity regulated pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(h)Licensed health care professional means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code, the Osteopathic Initiative Act or the Chiropractic Initiative Act, or Division 2.5 (commencing with Section 1797) of the Health and Safety Code.
(i)Marketing means to make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service.
Marketing does not include any of the following:
(1)Communications made orally or in writing for which the communicator does not receive direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication.
(2)Communications made to current enrollees solely for the purpose of describing a providers participation in an existing health care provider network or health plan network of a Knox-Keene licensed health plan to which the enrollees already subscribe; communications made to current enrollees solely for the purpose of describing if, and the extent to which, a product or service, or payment for a product or service, is provided by a provider, contractor, or plan or included in a plan of benefits of a Knox-Keene licensed health plan to which the enrollees already subscribe; or communications made to plan enrollees describing the availability of more cost-effective pharmaceuticals.
(3)Communications that are tailored to the circumstances of a particular individual to educate or advise the individual about treatment options, and otherwise maintain the individuals adherence to a prescribed course of medical treatment, as provided in Section 1399.901 of the Health and Safety Code, for a chronic and seriously debilitating or life-threatening condition as defined in subdivisions (d) and (e) of Section 1367.21 of the Health and Safety Code, if the health care provider, contractor, or health plan receives direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication, if all of the following apply:
(A)The individual receiving the communication is notified in the communication in typeface no smaller than 14-point type of the fact that the provider, contractor, or health plan has been remunerated and the source of the remuneration.
(B)The individual is provided the opportunity to opt out of receiving future remunerated communications.
(C)The communication contains instructions in typeface no smaller than 14-point type describing how the individual can opt out of receiving further communications by calling a toll-free number of the health care provider, contractor, or health plan making the remunerated communications. Further communication shall not be made to an individual who has opted out after 30 calendar days from the date the individual makes the opt-out request.
(j)Medical information means any individually identifiable information, in electronic or physical form, in possession of or derived from a provider of health care, health care service plan, pharmaceutical company, or contractor regarding a patients medical history, mental health application information, mental or physical condition, or treatment. Individually identifiable means that the medical information includes or contains any element of personal identifying information sufficient to allow identification of the individual, such as the patients name, address, electronic mail address, telephone number, or social security number, or other information that, alone or in combination with other publicly available information, reveals the identity of the individual.
(k)Mental health application information means information related to a consumers inferred or diagnosed mental health or substance use disorder, as defined in Section 1374.72 of the Health and Safety Code, collected by a mental health digital service.
(l)Mental health digital service means a mobile-based application or internet website that collects mental health application information from a consumer, markets itself as facilitating mental health services to a consumer, and uses the information to facilitate mental health services to a consumer.
(m)Patient means a natural person, whether or not still living, who received health care services from a provider of health care and to whom medical information pertains.
(n)Pharmaceutical company means a company or business, or an agent or representative thereof, that manufactures, sells, or distributes pharmaceuticals, medications, or prescription drugs. Pharmaceutical company does not include a pharmaceutical benefits manager, as included in subdivision (c), or a provider of health care.
(o)Protected individual means any adult covered by the subscribers health care service plan or a minor who can consent to a health care service without the consent of a parent or legal guardian, pursuant to state or federal law. Protected individual does not include an individual that lacks the capacity to give informed consent for health care pursuant to Section 813 of the Probate Code.
(p)Provider of health care means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code; a person licensed pursuant to the Osteopathic Initiative Act or the Chiropractic Initiative Act; a person certified pursuant to Division 2.5 (commencing with Section 1797) of the Health and Safety Code; or a clinic, health dispensary, or health facility licensed pursuant to Division 2 (commencing with Section 1200) of the Health and Safety Code. Provider of health care does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code.
(q)Sensitive services means all health care services related to mental or behavioral health, sexual and reproductive health, sexually transmitted infections, substance use disorder, gender affirming care, and intimate partner violence, and includes services described in Sections 6924, 6925, 6926, 6927, 6928, 6929, and 6930 of the Family Code, and Sections 121020 and 124260 of the Health and Safety Code, obtained by a patient at or above the minimum age specified for consenting to the service specified in the section.
(r)Subscriber has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
SEC. 1.5.Section 56.05 of the Civil Code is amended to read:56.05.For purposes of this part:
(a)Authorization means permission granted in accordance with Section 56.11 or 56.21 for the disclosure of medical information.
(b)Authorized recipient means a person who is authorized to receive medical information pursuant to Section 56.10 or 56.20.
(c)Confidential communications request means a request by a subscriber or enrollee that health care service plan communications containing medical information be communicated to them at a specific mail or email address or specific telephone number, as designated by the subscriber or enrollee.
(d)Contractor means a person or entity that is a medical group, independent practice association, pharmaceutical benefits manager, or a medical service organization and is not a health care service plan or provider of health care. Contractor does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code or pharmaceutical benefits managers licensed pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(e)Enrollee has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
(f)Expiration date or event means a specified date or an occurrence relating to the individual to whom the medical information pertains or the purpose of the use or disclosure, after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(g)Health care service plan means an entity regulated pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(h)Licensed health care professional means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code, the Osteopathic Initiative Act or the Chiropractic Initiative Act, or Division 2.5 (commencing with Section 1797) of the Health and Safety Code.
(i)Marketing means to make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service.
Marketing does not include any of the following:
(1)Communications made orally or in writing for which the communicator does not receive direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication.
(2)Communications made to current enrollees solely for the purpose of describing a providers participation in an existing health care provider network or health plan network of a Knox-Keene licensed health plan to which the enrollees already subscribe; communications made to current enrollees solely for the purpose of describing if, and the extent to which, a product or service, or payment for a product or service, is provided by a provider, contractor, or plan or included in a plan of benefits of a Knox-Keene licensed health plan to which the enrollees already subscribe; or communications made to plan enrollees describing the availability of more cost-effective pharmaceuticals.
(3)Communications that are tailored to the circumstances of a particular individual to educate or advise the individual about treatment options, and otherwise maintain the individuals adherence to a prescribed course of medical treatment, as provided in Section 1399.901 of the Health and Safety Code, for a chronic and seriously debilitating or life-threatening condition as defined in subdivisions (d) and (e) of Section 1367.21 of the Health and Safety Code, if the health care provider, contractor, or health plan receives direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication, if all of the following apply:
(A)The individual receiving the communication is notified in the communication in typeface no smaller than 14-point type of the fact that the provider, contractor, or health plan has been remunerated and the source of the remuneration.
(B)The individual is provided the opportunity to opt out of receiving future remunerated communications.
(C)The communication contains instructions in typeface no smaller than 14-point type describing how the individual can opt out of receiving further communications by calling a toll-free number of the health care provider, contractor, or health plan making the remunerated communications. Further communication shall not be made to an individual who has opted out after 30 calendar days from the date the individual makes the opt-out request.
(j)Medical information means any individually identifiable information, in electronic or physical form, in possession of or derived from a provider of health care, health care service plan, pharmaceutical company, or contractor regarding a patients medical history, mental health application information, reproductive or sexual health application information, mental or physical condition, or treatment. Individually identifiable means that the medical information includes or contains any element of personal identifying information sufficient to allow identification of the individual, such as the patients name, address, electronic mail address, telephone number, or social security number, or other information that, alone or in combination with other publicly available information, reveals the identity of the individual.
(k)Mental health application information means information related to a consumers inferred or diagnosed mental health or substance use disorder, as defined in Section 1374.72 of the Health and Safety Code, collected by a mental health digital service.
(l)Mental health digital service means a mobile-based application or internet website that collects mental health application information from a consumer, markets itself as facilitating mental health services to a consumer, and uses the information to facilitate mental health services to a consumer.
(m)Patient means a natural person, whether or not still living, who received health care services from a provider of health care and to whom medical information pertains.
(n)Pharmaceutical company means a company or business, or an agent or representative thereof, that manufactures, sells, or distributes pharmaceuticals, medications, or prescription drugs. Pharmaceutical company does not include a pharmaceutical benefits manager, as included in subdivision (c), or a provider of health care.
(o)Protected individual means any adult covered by the subscribers health care service plan or a minor who can consent to a health care service without the consent of a parent or legal guardian, pursuant to state or federal law. Protected individual does not include an individual that lacks the capacity to give informed consent for health care pursuant to Section 813 of the Probate Code.
(p)Provider of health care means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code; a person licensed pursuant to the Osteopathic Initiative Act or the Chiropractic Initiative Act; a person certified pursuant to Division 2.5 (commencing with Section 1797) of the Health and Safety Code; or a clinic, health dispensary, or health facility licensed pursuant to Division 2 (commencing with Section 1200) of the Health and Safety Code. Provider of health care does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code.
(q)Reproductive or sexual health application information means information about a consumers reproductive health, menstrual cycle, fertility, pregnancy, pregnancy outcome, plans to conceive, or type of sexual activity collected by a reproductive or sexual health digital service, including, but not limited to, information from which one can infer someones pregnancy status, menstrual cycle, fertility, hormone levels, birth control use, sexual activity, or gender identity.
(r)Reproductive or sexual health digital service means a mobile-based application or internet website that collects reproductive or sexual health application information from a consumer, markets itself as facilitating reproductive or sexual health services to a consumer, and uses the information to facilitate reproductive or sexual health services to a consumer.
(s)Sensitive services means all health care services related to mental or behavioral health, sexual and reproductive health, sexually transmitted infections, substance use disorder, gender affirming care, and intimate partner violence, and includes services described in Sections 6924, 6925, 6926, 6927, 6928, 6929, and 6930 of the Family Code, and Sections 121020 and 124260 of the Health and Safety Code, obtained by a patient at or above the minimum age specified for consenting to the service specified in the section.
(t)Subscriber has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
SEC. 2.Section 56.11 of the Civil Code is amended to read:56.11.(a)Any person or entity that wishes to obtain medical information pursuant to subdivision (a) of Section 56.10, other than a person or entity authorized to receive medical information pursuant to subdivision (b) or (c) of Section 56.10, except as provided in paragraph (21) of subdivision (c) of Section 56.10, shall obtain a valid authorization for the release of this information.
(b)An authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor shall be valid if it meets the following conditions:
(1)Is handwritten or is in a typeface no smaller than 14-point type.
(2)Is clearly separate from any other language present on the same page and is executed by a signature that serves no other purpose than to execute the authorization.
(3)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(A)The patient. A patient who is a minor may only sign an authorization for the release of medical information obtained by a provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which the minor could lawfully have consented under Part 4 (commencing with Section 6900) of Division 11 of the Family Code.
(B)The legal representative of the patient, if the patient is a minor or lacks the capacity to make the decision to authorize the release of medical information. However, authorization may not be given under this subdivision for the disclosure of medical information obtained by the provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which a minor patient could lawfully have consented under Part 4 (commencing with Section 6900) of Division 11 of the Family Code.
(C)The spouse of the patient or the person financially responsible for the patient, where the medical information is being sought for the sole purpose of processing an application for health insurance or for enrollment in a nonprofit hospital plan, a health care service plan, or an employee benefit plan, and where the patient is to be an enrolled spouse or dependent under the policy or plan.
(D)The beneficiary, as defined in Section 24 of the Probate Code, or personal representative, as defined in Section 58 of the Probate Code, of a deceased patient.
(4)States the specific uses and limitations on the types of medical information to be disclosed.
(5)States the name or functions of the provider of health care, health care service plan, pharmaceutical company, or contractor that may disclose the medical information.
(6)States the name or functions of the persons or entities authorized to receive the medical information.
(7)States the specific uses and limitations on the use of the medical information by the persons or entities authorized to receive the medical information.
(8)States an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(9)Advises the person signing the authorization of the right to receive a copy of the authorization.
(c)If a provider of health care, health care service plan, pharmaceutical company, contractor, or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the provider of health care, health care service plan, pharmaceutical company, contractor, or other entity shall provide the individual with a copy of the signed authorization, and instructions on how to access additional copies or a digital version of the signed authorization.
SEC. 3.Section 56.17 of the Civil Code is amended to read:56.17.(a)This section shall apply to the disclosure of genetic test results by a health care service plan that are contained in an applicants or enrollees medical records.
(b)Any person who negligently discloses results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not to exceed one thousand dollars ($1,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(c)Any person who willfully discloses the results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not less than one thousand dollars ($1,000) and no more than five thousand dollars ($5,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(d)Any person who willfully or negligently discloses the results of a test for a genetic characteristic to a third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), that results in economic, bodily, or emotional harm to the subject of the test, is guilty of a misdemeanor punishable by a fine not to exceed ten thousand dollars ($10,000).
(e)In addition to the penalties listed in subdivisions (b) and (c), any person who commits any act described in subdivision (b) or (c) shall be liable to the subject for all actual damages, including damages for economic, bodily, or emotional harm which is proximately caused by the act.
(f)Each disclosure made in violation of this section is a separate and actionable offense.
(g)The applicants written authorization, as used in this section, shall satisfy the following requirements:
(1)Is written in plain language and is in a typeface no smaller than 14-point type.
(2)Is dated and signed, including with an electronic or handwritten signature, by the individual or a person authorized to act on behalf of the individual.
(3)Specifies the types of persons authorized to disclose information about the individual.
(4)Specifies the nature of the information authorized to be disclosed.
(5)States the name or functions of the persons or entities authorized to receive the information.
(6)Specifies the purposes for which the information is collected.
(7)Specifies the length of time the authorization shall remain valid or states an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(8)Advises the person signing the authorization of the right to receive a copy of the authorization. Written authorization is required for each separate disclosure of the test results.
(h)If a provider of health care, health care service plan, pharmaceutical company, contractor, or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the provider of health care, health care service plan, pharmaceutical company, contractor, or other entity shall provide the individual with a copy of the signed authorization and instructions on how to access additional copies or a digital version of the signed authorization.
(i)This section shall not apply to disclosures required by the State Department of Health Care Services necessary to monitor compliance with Chapter 1 (commencing with Section 124975) of Part 5 of Division 106 of the Health and Safety Code, nor to disclosures required by the Department of Managed Health Care necessary to administer and enforce compliance with Section 1374.7 of the Health and Safety Code.
(j)For purposes of this section, genetic characteristic has the same meaning as that set forth in subdivision (d) of Section 1374.7 of the Health and Safety Code.
SEC. 4.Section 56.21 of the Civil Code is amended to read:56.21.An authorization for an employer to disclose medical information shall be valid if the authorization complies with all of the following:
(a)Is handwritten or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization.
(c)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)The patient, except that a patient who is a minor may only sign an authorization for the disclosure of medical information obtained by a provider of health care in the course of furnishing services to which the minor could lawfully have consented under Part 4 (commencing with Section 6900) of Division 11 of the Family Code.
(2)The legal representative of the patient, if the patient is a minor or lacks the capacity to make the decision to authorize the release of medical information. However, authorization may not be given under this subdivision for the disclosure of medical information that pertains to a competent minor and that was created by a provider of health care in the course of furnishing services to which a minor patient could lawfully have consented under Part 4 (commencing with Section 6900) of Division 11 of the Family Code.
(3)The beneficiary, as defined in Section 24 of the Probate Code, or personal representative, as defined in Section 58 of the Probate Code, of a deceased patient.
(d)States the limitations, if any, on the types of medical information to be disclosed.
(e)States the name or functions of the employer or person authorized to disclose the medical information.
(f)States the names or functions of the persons or entities authorized to receive the medical information.
(g)States the limitations, if any, on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(i)Advises the person who signed the authorization of the right to receive a copy of the authorization.
(j)If an employer or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the employer or other entity shall provide the individual with a copy of the signed authorization and instructions on how to access additional copies or a digital version of the signed authorization.
SEC. 5.Section 1633.3 of the Civil Code is amended to read:1633.3.(a)Except as otherwise provided in subdivisions (b) and (c), this title applies to electronic records and electronic signatures relating to a transaction.
(b)This title does not apply to transactions subject to any of the following laws:
(1)A law governing the creation and execution of wills, codicils, or testamentary trusts.
(2)Division 1 (commencing with Section 1101) of the Uniform Commercial Code, except Sections 1206 and 1306.
(3)Divisions 3 (commencing with Section 3101), 4 (commencing with Section 4101), 5 (commencing with Section 5101), 8 (commencing with Section 8101), 9 (commencing with Section 9101), and 11 (commencing with Section 11101) of the Uniform Commercial Code.
(4)A law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed, including initialed, from the record. However, this paragraph does not apply to Section 1677 or 1678 of this code or Section 1298 of the Code of Civil Procedure.
(c)This title does not apply to any specific transaction described in Section 17511.5 of the Business and Professions Code, Section 798.14, 1133, or 1134 of, Section 1689.6, 1689.7, or 1689.13 of, Chapter 2.5 (commencing with Section 1695) of Title 5 of Part 2 of Division 3 of, Section 1720, 1785.15, 1789.14, 1789.16, or 1793.23 of, Chapter 1 (commencing with Section 1801) of Title 2 of Part 4 of Division 3 of, Section 1861.24, 1862.5, 1917.712, 1917.713, 1950.6, 1983, 2924b, 2924c, 2924f, 2924i, 2924j, 2924.3, or 2937 of, Article 1.5 (commencing with Section 2945) of Chapter 2 of Title 14 of Part 4 of Division 3 of, Section 2954.5 or 2963 of, Chapter 2b (commencing with Section 2981) or 2d (commencing with Section 2985.7) of Title 14 of Part 4 of Division 3 of, Section 3071.5 of, Part 5 (commencing with Section 4000) of Division 4 of, or Part 5.3 (commencing with Section 6500) of Division 4 of, this code, subdivision (b) of Section 18608 or Section 22328 of the Financial Code, Section 1358.15, 1365, 1368.01, 1368.1, 1371, or 18035.5 of the Health and Safety Code, Section 786 as it applies to individual and group disability policies, 10199.44, 10199.46, 10235.16, 10235.40, 11624.09, or 11624.1 of the Insurance Code, Section 779.1, 10010.1, or 16482 of the Public Utilities Code, or Section 9975 or 11738 of the Vehicle Code. An electronic record may not be substituted for any notice that is required to be sent pursuant to Section 1162 of the Code of Civil Procedure. This subdivision does not prohibit the recordation of any document with a county recorder by electronic means.
(d)This title applies to an electronic record or electronic signature otherwise excluded from the application of this title under subdivision (b) when used for a transaction subject to a law other than those specified in subdivision (b).
(e)A transaction subject to this title is also subject to other applicable substantive law.
(f)The exclusion of a transaction from the application of this title under subdivision (b) or (c) shall be construed only to exclude the transaction from the application of this title, but shall not be construed to prohibit the transaction from being conducted by electronic means if the transaction may be conducted by electronic means under any other applicable law.
(g)Notwithstanding subdivisions (b) and (c), this title shall apply to electronic records and electronic signatures relating to transactions conducted by a person licensed, certified, or registered pursuant to the Alarm Company Act (Chapter 11.6 (commencing with Section 7590) of Division 3 of the Business and Professions Code) for purposes of activities authorized by Section 7599.54 of the Business and Professions Code.
SEC. 6.Section 1.5 of this bill incorporates amendments to Section 56.05 of the Civil Code proposed by both this bill and Assembly Bill 254. That section of this bill shall only become operative if (1) both bills are enacted and become effective on or before January 1, 2024, (2) each bill amends Section 56.05 of the Civil Code, and (3) this bill is enacted after Assembly Bill 254, in which case Section 1 of this bill shall not become operative.
For purposes of this part:
(a)Authorization means permission granted in accordance with Section 56.11 or 56.21 for the disclosure of medical information.
(b)Authorized recipient means a person who is authorized to receive medical information pursuant to Section 56.10 or 56.20.
(c)Confidential communications request means a request by a subscriber or enrollee that health care service plan communications containing medical information be communicated to them at a specific mail or email address or specific telephone number, as designated by the subscriber or enrollee.
(d)Contractor means a person or entity that is a medical group, independent practice association, pharmaceutical benefits manager, or a medical service organization and is not a health care service plan or provider of health care. Contractor does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code or pharmaceutical benefits managers licensed pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(e)Enrollee has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
(f)Expiration date or event means a specified date or an occurrence relating to the individual to whom the medical information pertains or the purpose of the use or disclosure, after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(g)Health care service plan means an entity regulated pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(h)Licensed health care professional means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code, the Osteopathic Initiative Act or the Chiropractic Initiative Act, or Division 2.5 (commencing with Section 1797) of the Health and Safety Code.
(i)Marketing means to make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service.
Marketing does not include any of the following:
(1)Communications made orally or in writing for which the communicator does not receive direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication.
(2)Communications made to current enrollees solely for the purpose of describing a providers participation in an existing health care provider network or health plan network of a Knox-Keene licensed health plan to which the enrollees already subscribe; communications made to current enrollees solely for the purpose of describing if, and the extent to which, a product or service, or payment for a product or service, is provided by a provider, contractor, or plan or included in a plan of benefits of a Knox-Keene licensed health plan to which the enrollees already subscribe; or communications made to plan enrollees describing the availability of more cost-effective pharmaceuticals.
(3)Communications that are tailored to the circumstances of a particular individual to educate or advise the individual about treatment options, and otherwise maintain the individuals adherence to a prescribed course of medical treatment, as provided in Section 1399.901 of the Health and Safety Code, for a chronic and seriously debilitating or life-threatening condition as defined in subdivisions (d) and (e) of Section 1367.21 of the Health and Safety Code, if the health care provider, contractor, or health plan receives direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication, if all of the following apply:
(A)The individual receiving the communication is notified in the communication in typeface no smaller than 14-point type of the fact that the provider, contractor, or health plan has been remunerated and the source of the remuneration.
(B)The individual is provided the opportunity to opt out of receiving future remunerated communications.
(C)The communication contains instructions in typeface no smaller than 14-point type describing how the individual can opt out of receiving further communications by calling a toll-free number of the health care provider, contractor, or health plan making the remunerated communications. Further communication shall not be made to an individual who has opted out after 30 calendar days from the date the individual makes the opt-out request.
(j)Medical information means any individually identifiable information, in electronic or physical form, in possession of or derived from a provider of health care, health care service plan, pharmaceutical company, or contractor regarding a patients medical history, mental health application information, mental or physical condition, or treatment. Individually identifiable means that the medical information includes or contains any element of personal identifying information sufficient to allow identification of the individual, such as the patients name, address, electronic mail address, telephone number, or social security number, or other information that, alone or in combination with other publicly available information, reveals the identity of the individual.
(k)Mental health application information means information related to a consumers inferred or diagnosed mental health or substance use disorder, as defined in Section 1374.72 of the Health and Safety Code, collected by a mental health digital service.
(l)Mental health digital service means a mobile-based application or internet website that collects mental health application information from a consumer, markets itself as facilitating mental health services to a consumer, and uses the information to facilitate mental health services to a consumer.
(m)Patient means a natural person, whether or not still living, who received health care services from a provider of health care and to whom medical information pertains.
(n)Pharmaceutical company means a company or business, or an agent or representative thereof, that manufactures, sells, or distributes pharmaceuticals, medications, or prescription drugs. Pharmaceutical company does not include a pharmaceutical benefits manager, as included in subdivision (c), or a provider of health care.
(o)Protected individual means any adult covered by the subscribers health care service plan or a minor who can consent to a health care service without the consent of a parent or legal guardian, pursuant to state or federal law. Protected individual does not include an individual that lacks the capacity to give informed consent for health care pursuant to Section 813 of the Probate Code.
(p)Provider of health care means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code; a person licensed pursuant to the Osteopathic Initiative Act or the Chiropractic Initiative Act; a person certified pursuant to Division 2.5 (commencing with Section 1797) of the Health and Safety Code; or a clinic, health dispensary, or health facility licensed pursuant to Division 2 (commencing with Section 1200) of the Health and Safety Code. Provider of health care does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code.
(q)Sensitive services means all health care services related to mental or behavioral health, sexual and reproductive health, sexually transmitted infections, substance use disorder, gender affirming care, and intimate partner violence, and includes services described in Sections 6924, 6925, 6926, 6927, 6928, 6929, and 6930 of the Family Code, and Sections 121020 and 124260 of the Health and Safety Code, obtained by a patient at or above the minimum age specified for consenting to the service specified in the section.
(r)Subscriber has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
SEC. 1.5.Section 56.05 of the Civil Code is amended to read:56.05.For purposes of this part:
(a)Authorization means permission granted in accordance with Section 56.11 or 56.21 for the disclosure of medical information.
(b)Authorized recipient means a person who is authorized to receive medical information pursuant to Section 56.10 or 56.20.
(c)Confidential communications request means a request by a subscriber or enrollee that health care service plan communications containing medical information be communicated to them at a specific mail or email address or specific telephone number, as designated by the subscriber or enrollee.
(d)Contractor means a person or entity that is a medical group, independent practice association, pharmaceutical benefits manager, or a medical service organization and is not a health care service plan or provider of health care. Contractor does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code or pharmaceutical benefits managers licensed pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(e)Enrollee has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
(f)Expiration date or event means a specified date or an occurrence relating to the individual to whom the medical information pertains or the purpose of the use or disclosure, after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(f)(g)Health care service plan means an entity regulated pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(g)(h)Licensed health care professional means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code, the Osteopathic Initiative Act or the Chiropractic Initiative Act, or Division 2.5 (commencing with Section 1797) of the Health and Safety Code.
(h)(i)Marketing means to make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service.
Marketing does not include any of the following:
(1)Communications made orally or in writing for which the communicator does not receive direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication.
(2)Communications made to current enrollees solely for the purpose of describing a providers participation in an existing health care provider network or health plan network of a Knox-Keene licensed health plan to which the enrollees already subscribe; communications made to current enrollees solely for the purpose of describing if, and the extent to which, a product or service, or payment for a product or service, is provided by a provider, contractor, or plan or included in a plan of benefits of a Knox-Keene licensed health plan to which the enrollees already subscribe; or communications made to plan enrollees describing the availability of more cost-effective pharmaceuticals.
(3)Communications that are tailored to the circumstances of a particular individual to educate or advise the individual about treatment options, and otherwise maintain the individuals adherence to a prescribed course of medical treatment, as provided in Section 1399.901 of the Health and Safety Code, for a chronic and seriously debilitating or life-threatening condition as defined in subdivisions (d) and (e) of Section 1367.21 of the Health and Safety Code, if the health care provider, contractor, or health plan receives direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication, if all of the following apply:
(A)The individual receiving the communication is notified in the communication in typeface no smaller than 14-point type of the fact that the provider, contractor, or health plan has been remunerated and the source of the remuneration.
(B)The individual is provided the opportunity to opt out of receiving future remunerated communications.
(C)The communication contains instructions in typeface no smaller than 14-point type describing how the individual can opt out of receiving further communications by calling a toll-free number of the health care provider, contractor, or health plan making the remunerated communications. Further communication shall not be made to an individual who has opted out after 30 calendar days from the date the individual makes the opt-out request.
(i)(j)Medical information means any individually identifiable information, in electronic or physical form, in possession of or derived from a provider of health care, health care service plan, pharmaceutical company, or contractor regarding a patients medical history, mental health application information, reproductive or sexual health application information, mental or physical condition, or treatment. Individually identifiable means that the medical information includes or contains any element of personal identifying information sufficient to allow identification of the individual, such as the patients name, address, electronic mail address, telephone number, or social security number, or other information that, alone or in combination with other publicly available information, reveals the identity of the individual.
(j)(k)Mental health application information means information related to a consumers inferred or diagnosed mental health or substance use disorder, as defined in Section 1374.72 of the Health and Safety Code, collected by a mental health digital service.
(k)(l)Mental health digital service means a mobile-based application or internet website that collects mental health application information from a consumer, markets itself as facilitating mental health services to a consumer, and uses the information to facilitate mental health services to a consumer.
(l)(m)Patient means a natural person, whether or not still living, who received health care services from a provider of health care and to whom medical information pertains.
(m)(n)Pharmaceutical company means a company or business, or an agent or representative thereof, that manufactures, sells, or distributes pharmaceuticals, medications, or prescription drugs. Pharmaceutical company does not include a pharmaceutical benefits manager, as included in subdivision (c), or a provider of health care.
(n)(o)Protected individual means any adult covered by the subscribers health care service plan or a minor who can consent to a health care service without the consent of a parent or legal guardian, pursuant to state or federal law. Protected individual does not include an individual that lacks the capacity to give informed consent for health care pursuant to Section 813 of the Probate Code.
(o)(p)Provider of health care means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code; a person licensed pursuant to the Osteopathic Initiative Act or the Chiropractic Initiative Act; a person certified pursuant to Division 2.5 (commencing with Section 1797) of the Health and Safety Code; or a clinic, health dispensary, or health facility licensed pursuant to Division 2 (commencing with Section 1200) of the Health and Safety Code. Provider of health care does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code.
(q)Reproductive or sexual health application information means information about a consumers reproductive health, menstrual cycle, fertility, pregnancy, pregnancy outcome, plans to conceive, or type of sexual activity collected by a reproductive or sexual health digital service, including, but not limited to, information from which one can infer someones pregnancy status, menstrual cycle, fertility, hormone levels, birth control use, sexual activity, or gender identity.
(r)Reproductive or sexual health digital service means a mobile-based application or internet website that collects reproductive or sexual health application information from a consumer, markets itself as facilitating reproductive or sexual health services to a consumer, and uses the information to facilitate reproductive or sexual health services to a consumer.
(p)(s)Sensitive services means all health care services related to mental or behavioral health, sexual and reproductive health, sexually transmitted infections, substance use disorder, gender affirming care, and intimate partner violence, and includes services described in Sections 6924, 6925, 6926, 6927, 6928, 6929, and 6930 of the Family Code, and Sections 121020 and 124260 of the Health and Safety Code, obtained by a patient at or above the minimum age specified for consenting to the service specified in the section.
(q)(t)Subscriber has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
SEC. 2.Section 56.11 of the Civil Code is amended to read:56.11.(a)Any person or entity that wishes to obtain medical information pursuant to subdivision (a) of Section 56.10, other than a person or entity authorized to receive medical information pursuant to subdivision (b) or (c) of Section 56.10, except as provided in paragraph (21) of subdivision (c) of Section 56.10, shall obtain a valid authorization for the release of this information.
An(b)An authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor shall be valid if the signatory pursuant to subdivision (c) receives a copy of that authorization and that authorization: it meets the following conditions:
(a)(1)Is handwritten or is in a typeface no smaller than 14-point type.
(b)(2)Is clearly separate from any other language present on the same page and is executed by a signature which that serves no other purpose than to execute the authorization.
(c)(3)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)(A)The patient. A patient who is a minor may only sign an authorization for the release of medical information obtained by a provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60). 4 (Commencing with Section 6900) of Division 11 of the Family Code.
(2)(B)The legal representative of the patient, if the patient is a minor or an incompetent. lacks the capacity to make the decision to authorize the release of medical information. However, authorization may not be given under this subdivision for the disclosure of medical information obtained by the provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60). 4 (Commencing with Section 6900) of Division 11 of the Family Code.
(3)(C)The spouse of the patient or the person financially responsible for the patient, where the medical information is being sought for the sole purpose of processing an application for health insurance or for enrollment in a nonprofit hospital plan, a health care service plan, or an employee benefit plan, and where the patient is to be an enrolled spouse or dependent under the policy or plan.
(4)(D)The beneficiary beneficiary, as defined in Section 24 of the Probate Code, or personal representative representative, as defined in Section 58 of the Probate Code, of a deceased patient.
(d)(4)States the specific uses and limitations on the types of medical information to be disclosed.
(e)(5)States the name or functions of the provider of health care, health care service plan, pharmaceutical company, or contractor that may disclose the medical information.
(f)(6)States the name or functions of the persons or entities authorized to receive the medical information.
(g)(7)States the specific uses and limitations on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)(8)States an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(i)(9)Advises the person signing the authorization of the right to receive a copy of the authorization.
(c)If a provider of health care, health care service plan, pharmaceutical company, contractor, or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the provider of health care, health care service plan, pharmaceutical company, contractor, or other entity shall provide the individual with a copy of the signed authorization, and instructions on how to access additional copies or a digital version of the signed authorization.
SEC. 3.Section 56.17 of the Civil Code is amended to read:56.17.(a)This section shall apply to the disclosure of genetic test results by a health care service plan that are contained in an applicants or enrollees medical records by a health care service plan. records.
(b)Any person who negligently discloses results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not to exceed one thousand dollars ($1,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(c)Any person who willfully discloses the results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not less than one thousand dollars ($1,000) and no more than five thousand dollars ($5,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(d)Any person who willfully or negligently discloses the results of a test for a genetic characteristic to a third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), that results in economic, bodily, or emotional harm to the subject of the test, is guilty of a misdemeanor punishable by a fine not to exceed ten thousand dollars ($10,000).
(e)In addition to the penalties listed in subdivisions (b) and (c), any person who commits any act described in subdivision (b) or (c) shall be liable to the subject for all actual damages, including damages for economic, bodily, or emotional harm which is proximately caused by the act.
(f)Each disclosure made in violation of this section is a separate and actionable offense.
(g)The applicants written authorization, as used in this section, shall satisfy the following requirements:
(1)Is written in plain language and is in a typeface no smaller than 14-point type.
(2)Is dated and signed, including with an electronic or handwritten signature, by the individual or a person authorized to act on behalf of the individual.
(3)Specifies the types of persons authorized to disclose information about the individual.
(4)Specifies the nature of the information authorized to be disclosed.
(5)States the name or functions of the persons or entities authorized to receive the information.
(6)Specifies the purposes for which the information is collected.
(7)Specifies the length of time the authorization shall remain valid or states an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(8)Advises the person signing the authorization of the right to receive a copy of the authorization. Written authorization is required for each separate disclosure of the test results.
(h)The individual or person authorized to disclose information about the applicant shall provide a copy of the written authorization to the applicant or a person authorized to act on behalf of the applicant. If a provider of health care, health care service plan, pharmaceutical company, contractor, or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the provider of health care, health care service plan, pharmaceutical company, contractor, or other entity shall provide the individual with a copy of the signed authorization and instructions on how to access additional copies or a digital version of the signed authorization.
(i)This section shall not apply to disclosures required by the State Department of Health Care Services necessary to monitor compliance with Chapter 1 (commencing with Section 124975) of Part 5 of Division 106 of the Health and Safety Code, nor to disclosures required by the Department of Managed Health Care necessary to administer and enforce compliance with Section 1374.7 of the Health and Safety Code.
(j)For purposes of this section, genetic characteristic has the same meaning as that set forth in subdivision (d) of Section 1374.7 of the Health and Safety Code.
SEC. 4.Section 56.21 of the Civil Code is amended to read:56.21.An authorization for an employer to disclose medical information shall be valid if the employer provides a copy to the signatory pursuant to subdivision (c) and the authorization complies with all of the following:
(a)Is handwritten or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization.
(c)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)The patient, except that a patient who is a minor may only sign an authorization for the disclosure of medical information obtained by a provider of health care in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60) of Division 1. 4 (Commencing with Section 6900) of Division 11 of the Family Code.
(2)The legal representative of the patient, if the patient is a minor or incompetent. lacks the capacity to make the decision to authorize the release of medical information. However, authorization may not be given under this subdivision for the disclosure of medical information that pertains to a competent minor and that was created by a provider of health care in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60) of Division 1. 4 (Commencing with Section 6900) of Division 11 of the Family Code.
(3)The beneficiary beneficiary, as defined in Section 24 of the Probate Code, or personal representative representative, as defined in Section 58 of the Probate Code, of a deceased patient.
(d)States the limitations, if any, on the types of medical information to be disclosed.
(e)States the name or functions of the employer or person authorized to disclose the medical information.
(f)States the names or functions of the persons or entities authorized to receive the medical information.
(g)States the limitations, if any, on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the person signing the authorization requests a specific date beyond a year or unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(i)Advises the person who signed the authorization of the right to receive a copy of the authorization.
(j)If an employer or any other entity seeks an authorization from an individual for a use or disclosure of protected health information, the employer or other entity shall provide the individual with a copy of the signed authorization and instructions on how to access additional copies or a digital version of the signed authorization.
SEC. 5.Section 1633.3 of the Civil Code is amended to read:1633.3.(a)Except as otherwise provided in subdivisions (b) and (c), this title applies to electronic records and electronic signatures relating to a transaction.
(b)This title does not apply to transactions subject to any of the following laws:
(1)A law governing the creation and execution of wills, codicils, or testamentary trusts.
(2)Division 1 (commencing with Section 1101) of the Uniform Commercial Code, except Sections 1206 and 1306.
(3)Divisions 3 (commencing with Section 3101), 4 (commencing with Section 4101), 5 (commencing with Section 5101), 8 (commencing with Section 8101), 9 (commencing with Section 9101), and 11 (commencing with Section 11101) of the Uniform Commercial Code.
(4)A law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed, including initialed, from the record. However, this paragraph does not apply to Section 1677 or 1678 of this code or Section 1298 of the Code of Civil Procedure.
(c)This title does not apply to any specific transaction described in Section 17511.5 of the Business and Professions Code, Section 798.14, 1133, or 1134 of, Section 1689.6, 1689.7, or 1689.13 of, Chapter 2.5 (commencing with Section 1695) of Title 5 of Part 2 of Division 3 of, Section 1720, 1785.15, 1789.14, 1789.16, or 1793.23 of, Chapter 1 (commencing with Section 1801) of Title 2 of Part 4 of Division 3 of, Section 1861.24, 1862.5, 1917.712, 1917.713, 1950.6, 1983, 2924b, 2924c, 2924f, 2924i, 2924j, 2924.3, or 2937 of, Article 1.5 (commencing with Section 2945) of Chapter 2 of Title 14 of Part 4 of Division 3 of, Section 2954.5 or 2963 of, Chapter 2b (commencing with Section 2981) or 2d (commencing with Section 2985.7) of Title 14 of Part 4 of Division 3 of, Section 3071.5 of, Part 5 (commencing with Section 4000) of Division 4 of, or Part 5.3 (commencing with Section 6500) of Division 4 of, this code, subdivision (b) of Section 18608 or Section 22328 of the Financial Code, Section 1358.15, 1365, 1368.01, 1368.1, 1371, or 18035.5 of the Health and Safety Code, Section 786 as it applies to individual and group disability policies, 10199.44, 10199.46, 10235.16, 10235.40, 11624.09, or 11624.1 of the Insurance Code, Section 779.1, 10010.1, or 16482 of the Public Utilities Code, or Section 9975 or 11738 of the Vehicle Code. An electronic record may not be substituted for any notice that is required to be sent pursuant to Section 1162 of the Code of Civil Procedure. This subdivision does not prohibit the recordation of any document with a county recorder by electronic means.
(d)This title applies to an electronic record or electronic signature otherwise excluded from the application of this title under subdivision (b) when used for a transaction subject to a law other than those specified in subdivision (b).
(e)A transaction subject to this title is also subject to other applicable substantive law.
(f)The exclusion of a transaction from the application of this title under subdivision (b) or (c) shall be construed only to exclude the transaction from the application of this title, but shall not be construed to prohibit the transaction from being conducted by electronic means if the transaction may be conducted by electronic means under any other applicable law.
(g)Notwithstanding subdivisions (b) and (c), this title shall apply to electronic records and electronic signatures relating to transactions conducted by a person licensed, certified, or registered pursuant to the Alarm Company Act (Chapter 11.6 (commencing with Section 7590) of Division 3 of the Business and Professions Code) for purposes of activities authorized by Section 7599.54 of the Business and Professions Code.
SEC. 6.Section 1.5 of this bill incorporates amendments to Section 56.05 of the Civil Code proposed by both this bill and Assembly Bill 254. That section of this bill shall only become operative if (1) both bills are enacted and become effective on or before January 1, 2024, (2) each bill amends Section 56.05 of the Civil Code, and (3) this bill is enacted after Assembly Bill 254, in which case Section 1 of this bill shall not become operative.
For purposes of this part:
(a)Authorization means permission granted in accordance with Section 56.11 or 56.21 for the disclosure of medical information.
(b)Authorized recipient means a person who is authorized to receive medical information pursuant to Section 56.10 or 56.20.
(c)Confidential communications request means a request by a subscriber or enrollee that health care service plan communications containing medical information be communicated to them at a specific mail or email address or specific telephone number, as designated by the subscriber or enrollee.
(d)Contractor means a person or entity that is a medical group, independent practice association, pharmaceutical benefits manager, or a medical service organization and is not a health care service plan or provider of health care. Contractor does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code or pharmaceutical benefits managers licensed pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(e)Enrollee has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
(f)Expiration date or event means a specified date or an occurrence relating to the individual to whom the medical information pertains or the purpose of the use or disclosure, after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(f)(g)Health care service plan means an entity regulated pursuant to the Knox-Keene Health Care Service Plan Act of 1975 (Chapter 2.2 (commencing with Section 1340) of Division 2 of the Health and Safety Code).
(g)(h)Licensed health care professional means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code, the Osteopathic Initiative Act or the Chiropractic Initiative Act, or Division 2.5 (commencing with Section 1797) of the Health and Safety Code.
(h)(i)Marketing means to make a communication about a product or service that encourages recipients of the communication to purchase or use the product or service.
Marketing does not include any of the following:
(1)Communications made orally or in writing for which the communicator does not receive direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication.
(2)Communications made to current enrollees solely for the purpose of describing a providers participation in an existing health care provider network or health plan network of a Knox-Keene licensed health plan to which the enrollees already subscribe; communications made to current enrollees solely for the purpose of describing if, and the extent to which, a product or service, or payment for a product or service, is provided by a provider, contractor, or plan or included in a plan of benefits of a Knox-Keene licensed health plan to which the enrollees already subscribe; or communications made to plan enrollees describing the availability of more cost-effective pharmaceuticals.
(3)Communications that are tailored to the circumstances of a particular individual to educate or advise the individual about treatment options, and otherwise maintain the individuals adherence to a prescribed course of medical treatment, as provided in Section 1399.901 of the Health and Safety Code, for a chronic and seriously debilitating or life-threatening condition as defined in subdivisions (d) and (e) of Section 1367.21 of the Health and Safety Code, if the health care provider, contractor, or health plan receives direct or indirect remuneration, including, but not limited to, gifts, fees, payments, subsidies, or other economic benefits, from a third party for making the communication, if all of the following apply:
(A)The individual receiving the communication is notified in the communication in typeface no smaller than 14-point type of the fact that the provider, contractor, or health plan has been remunerated and the source of the remuneration.
(B)The individual is provided the opportunity to opt out of receiving future remunerated communications.
(C)The communication contains instructions in typeface no smaller than 14-point type describing how the individual can opt out of receiving further communications by calling a toll-free number of the health care provider, contractor, or health plan making the remunerated communications. Further communication shall not be made to an individual who has opted out after 30 calendar days from the date the individual makes the opt-out request.
(i)(j)Medical information means any individually identifiable information, in electronic or physical form, in possession of or derived from a provider of health care, health care service plan, pharmaceutical company, or contractor regarding a patients medical history, mental health application information, mental or physical condition, or treatment. Individually identifiable means that the medical information includes or contains any element of personal identifying information sufficient to allow identification of the individual, such as the patients name, address, electronic mail address, telephone number, or social security number, or other information that, alone or in combination with other publicly available information, reveals the identity of the individual.
(j)(k)Mental health application information means information related to a consumers inferred or diagnosed mental health or substance use disorder, as defined in Section 1374.72 of the Health and Safety Code, collected by a mental health digital service.
(k)(l)Mental health digital service means a mobile-based application or internet website that collects mental health application information from a consumer, markets itself as facilitating mental health services to a consumer, and uses the information to facilitate mental health services to a consumer.
(l)(m)Patient means a natural person, whether or not still living, who received health care services from a provider of health care and to whom medical information pertains.
(m)(n)Pharmaceutical company means a company or business, or an agent or representative thereof, that manufactures, sells, or distributes pharmaceuticals, medications, or prescription drugs. Pharmaceutical company does not include a pharmaceutical benefits manager, as included in subdivision (c), or a provider of health care.
(n)(o)Protected individual means any adult covered by the subscribers health care service plan or a minor who can consent to a health care service without the consent of a parent or legal guardian, pursuant to state or federal law. Protected individual does not include an individual that lacks the capacity to give informed consent for health care pursuant to Section 813 of the Probate Code.
(o)(p)Provider of health care means a person licensed or certified pursuant to Division 2 (commencing with Section 500) of the Business and Professions Code; a person licensed pursuant to the Osteopathic Initiative Act or the Chiropractic Initiative Act; a person certified pursuant to Division 2.5 (commencing with Section 1797) of the Health and Safety Code; or a clinic, health dispensary, or health facility licensed pursuant to Division 2 (commencing with Section 1200) of the Health and Safety Code. Provider of health care does not include insurance institutions as defined in subdivision (k) of Section 791.02 of the Insurance Code.
(p)(q)Sensitive services means all health care services related to mental or behavioral health, sexual and reproductive health, sexually transmitted infections, substance use disorder, gender affirming care, and intimate partner violence, and includes services described in Sections 6924, 6925, 6926, 6927, 6928, 6929, and 6930 of the Family Code, and Sections 121020 and 124260 of the Health and Safety Code, obtained by a patient at or above the minimum age specified for consenting to the service specified in the section.
(q)(r)Subscriber has the same meaning as that term is defined in Section 1345 of the Health and Safety Code.
SECTION 1.SEC. 2.Section 56.11 of the Civil Code is amended to read:56.11.Any person or entity that wishes to obtain medical information pursuant to subdivision (a) of Section 56.10, other than a person or entity authorized to receive medical information pursuant to subdivision (b) or (c) of Section 56.10, except as provided in paragraph (21) of subdivision (c) of Section 56.10, shall obtain a valid authorization for the release of this information.
An authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor shall be valid if it: the signatory pursuant to subdivision (c) receives a copy of that authorization and that authorization:
(a)Is handwritten or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature which serves no other purpose than to execute the authorization.
(c)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)The patient. A patient who is a minor may only sign an authorization for the release of medical information obtained by a provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60).
(2)The legal representative of the patient, if the patient is a minor or an incompetent. However, authorization may not be given under this subdivision for the disclosure of medical information obtained by the provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60).
(3)The spouse of the patient or the person financially responsible for the patient, where the medical information is being sought for the sole purpose of processing an application for health insurance or for enrollment in a nonprofit hospital plan, a health care service plan, or an employee benefit plan, and where the patient is to be an enrolled spouse or dependent under the policy or plan.
(4)The beneficiary or personal representative of a deceased patient.
(d)States the specific uses and limitations on the types of medical information to be disclosed.
(e)States the name or functions of the provider of health care, health care service plan, pharmaceutical company, or contractor that may disclose the medical information.
(f)States the name or functions of the persons or entities authorized to receive the medical information.
(g)States the specific uses and limitations on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States a specific date or an expiration event after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information. date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(i)Advises the person signing the authorization of the right to receive a copy of the authorization.
(j)For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement end of the research study, none, or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository.SEC. 2.SEC. 3.Section 56.17 of the Civil Code is amended to read:56.17.(a)This section shall apply to the disclosure of genetic test results contained in an applicants or enrollees medical records by a health care service plan.
(b)Any person who negligently discloses results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not to exceed one thousand dollars ($1,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(c)Any person who willfully discloses the results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not less than one thousand dollars ($1,000) and no more than five thousand dollars ($5,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(d)Any person who willfully or negligently discloses the results of a test for a genetic characteristic to a third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), that results in economic, bodily, or emotional harm to the subject of the test, is guilty of a misdemeanor punishable by a fine not to exceed ten thousand dollars ($10,000).
(e)In addition to the penalties listed in subdivisions (b) and (c), any person who commits any act described in subdivision (b) or (c) shall be liable to the subject for all actual damages, including damages for economic, bodily, or emotional harm which is proximately caused by the act.
(f)Each disclosure made in violation of this section is a separate and actionable offense.
(g)The applicants written authorization, as used in this section, shall satisfy the following requirements:
(1)Is written in plain language and is in a typeface no smaller than 14-point type.
(2)Is dated and signed, including with an electronic or handwritten signature, by the individual or a person authorized to act on behalf of the individual.
(3)Specifies the types of persons authorized to disclose information about the individual.
(4)Specifies the nature of the information authorized to be disclosed.
(5)States the name or functions of the persons or entities authorized to receive the information.
(6)Specifies the purposes for which the information is collected.
(7)Specifies the length of time the authorization shall remain valid or describes an expiration event. states an expiration date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(8)Advises the person signing the authorization of the right to receive a copy of the authorization. Written authorization is required for each separate disclosure of the test results.
(h)The individual or person authorized to disclose information about the applicant shall provide a copy of the written authorization to the applicant or a person authorized to act on behalf of the applicant.
(h)(i)This section shall not apply to disclosures required by the State Department of Health Care Services necessary to monitor compliance with Chapter 1 (commencing with Section 124975) of Part 5 of Division 106 of the Health and Safety Code, nor to disclosures required by the Department of Managed Health Care necessary to administer and enforce compliance with Section 1374.7 of the Health and Safety Code.
(i)(j)For purposes of this section, genetic characteristic has the same meaning as that set forth in subdivision (d) of Section 1374.7 of the Health and Safety Code.
(j)For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement end of the research study, none, or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repositorySEC. 3.SEC. 4.Section 56.21 of the Civil Code is amended to read:56.21.An authorization for an employer to disclose medical information shall be valid if it the employer provides a copy to the signatory pursuant to subdivision (c) and the authorization complies with all of the following:
(a)Is handwritten or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization.
(c)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)The patient, except that a patient who is a minor may only sign an authorization for the disclosure of medical information obtained by a provider of health care in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60) of Division 1.
(2)The legal representative of the patient, if the patient is a minor or incompetent. However, authorization may not be given under this subdivision for the disclosure of medical information that pertains to a competent minor and that was created by a provider of health care in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60) of Division 1.
(3)The beneficiary or personal representative of a deceased patient.
(d)States the limitations, if any, on the types of medical information to be disclosed.
(e)States the name or functions of the employer or person authorized to disclose the medical information.
(f)States the names or functions of the persons or entities authorized to receive the medical information.
(g)States the limitations, if any, on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States a specific date or an expiration event after which the employer is no longer authorized to disclose the medical information. date or event. The expiration date or event shall limit the duration of the authorization to one year or less, unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
(i)Advises the person who signed the authorization of the right to receive a copy of the authorization.
(j)For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement end of the research study, none, or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repositorySEC. 4.SEC. 5.Section 1633.3 of the Civil Code is amended to read:1633.3.(a)Except as otherwise provided in subdivisions (b) and (c), this title applies to electronic records and electronic signatures relating to a transaction.
(b)This title does not apply to transactions subject to any of the following laws:
(1)A law governing the creation and execution of wills, codicils, or testamentary trusts.
(2)Division 1 (commencing with Section 1101) of the Uniform Commercial Code, except Sections 1206 and 1306.
(3)Divisions 3 (commencing with Section 3101), 4 (commencing with Section 4101), 5 (commencing with Section 5101), 8 (commencing with Section 8101), 9 (commencing with Section 9101), and 11 (commencing with Section 11101) of the Uniform Commercial Code.
(4)A law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed, including initialed, from the record. However, this paragraph does not apply to Section 1677 or 1678 of this code or Section 1298 of the Code of Civil Procedure.
(c)This title does not apply to any specific transaction described in Section 17511.5 of the Business and Professions Code, Section 798.14, 1133, or 1134 of, Section 1689.6, 1689.7, or 1689.13 of, Chapter 2.5 (commencing with Section 1695) of Title 5 of Part 2 of Division 3 of, Section 1720, 1785.15, 1789.14, 1789.16, or 1793.23 of, Chapter 1 (commencing with Section 1801) of Title 2 of Part 4 of Division 3 of, Section 1861.24, 1862.5, 1917.712, 1917.713, 1950.6, 1983, 2924b, 2924c, 2924f, 2924i, 2924j, 2924.3, or 2937 of, Article 1.5 (commencing with Section 2945) of Chapter 2 of Title 14 of Part 4 of Division 3 of, Section 2954.5 or 2963 of, Chapter 2b (commencing with Section 2981) or 2d (commencing with Section 2985.7) of Title 14 of Part 4 of Division 3 of, Section 3071.5 of, Part 5 (commencing with Section 4000) of Division 4 of, or Part 5.3 (commencing with Section 6500) of Division 4 of, this code, subdivision (b) of Section 18608 or Section 22328 of the Financial Code, Section 1358.15, 1365, 1368.01, 1368.1, 1371, or 18035.5 of the Health and Safety Code, Section 786 as it applies to individual and group disability policies, 10199.44, 10199.46, 10235.16, 10235.40, 11624.09, or 11624.1 of the Insurance Code, Section 779.1, 10010.1, or 16482 of the Public Utilities Code, or Section 9975 or 11738 of the Vehicle Code. An electronic record may not be substituted for any notice that is required to be sent pursuant to Section 1162 of the Code of Civil Procedure. This subdivision does not prohibit the recordation of any document with a county recorder by electronic means.
(d)This title applies to an electronic record or electronic signature otherwise excluded from the application of this title under subdivision (b) when used for a transaction subject to a law other than those specified in subdivision (b).
(e)A transaction subject to this title is also subject to other applicable substantive law.
(f)The exclusion of a transaction from the application of this title under subdivision (b) or (c) shall be construed only to exclude the transaction from the application of this title, but shall not be construed to prohibit the transaction from being conducted by electronic means if the transaction may be conducted by electronic means under any other applicable law.
(g)Notwithstanding subdivisions (b) and (c), this title shall apply to electronic records and electronic signatures relating to transactions conducted by a person licensed, certified, or registered pursuant to the Alarm Company Act (Chapter 11.6 (commencing with Section 7590) of Division 3 of the Business and Professions Code) for purposes of activities authorized by Section 7599.54 of the Business and Professions Code.
Any person or entity that wishes to obtain medical information pursuant to subdivision (a) of Section 56.10, other than a person or entity authorized to receive medical information pursuant to subdivision (b) or (c) of Section 56.10, except as provided in paragraph (21) of subdivision (c) of Section 56.10, shall obtain a valid authorization for the release of this information.
An authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor shall be valid if it:
(a)Is handwritten or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature which serves no other purpose than to execute the authorization.
(c)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)The patient. A patient who is a minor may only sign an authorization for the release of medical information obtained by a provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60).
(2)The legal representative of the patient, if the patient is a minor or an incompetent. However, authorization may not be given under this subdivision for the disclosure of medical information obtained by the provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60).
(3)The spouse of the patient or the person financially responsible for the patient, where the medical information is being sought for the sole purpose of processing an application for health insurance or for enrollment in a nonprofit hospital plan, a health care service plan, or an employee benefit plan, and where the patient is to be an enrolled spouse or dependent under the policy or plan.
(4)The beneficiary or personal representative of a deceased patient.
(d)States the specific uses and limitations on the types of medical information to be disclosed.
(e)States the name or functions of the provider of health care, health care service plan, pharmaceutical company, or contractor that may disclose the medical information.
(f)States the name or functions of the persons or entities authorized to receive the medical information.
(g)States the specific uses and limitations on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States a specific date or expiration event after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(i)Advises the person signing the authorization of the right to receive a copy of the authorization.
(j)For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement end of the research study, none, or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository.
SEC. 2.Section 56.17 of the Civil Code is amended to read:56.17.(a)This section shall apply to the disclosure of genetic test results contained in an applicants or enrollees medical records by a health care service plan.
(b)Any person who negligently discloses results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not to exceed one thousand dollars ($1,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(c)Any person who willfully discloses the results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not less than one thousand dollars ($1,000) and no more than five thousand dollars ($5,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(d)Any person who willfully or negligently discloses the results of a test for a genetic characteristic to a third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), that results in economic, bodily, or emotional harm to the subject of the test, is guilty of a misdemeanor punishable by a fine not to exceed ten thousand dollars ($10,000).
(e)In addition to the penalties listed in subdivisions (b) and (c), any person who commits any act described in subdivision (b) or (c) shall be liable to the subject for all actual damages, including damages for economic, bodily, or emotional harm which is proximately caused by the act.
(f)Each disclosure made in violation of this section is a separate and actionable offense.
(g)The applicants written authorization, as used in this section, shall satisfy the following requirements:
(1)Is written in plain language and is in a typeface no smaller than 14-point type.
(2)Is dated and signed, including with an electronic or handwritten signature, by the individual or a person authorized to act on behalf of the individual.
(3)Specifies the types of persons authorized to disclose information about the individual.
(4)Specifies the nature of the information authorized to be disclosed.
(5)States the name or functions of the persons or entities authorized to receive the information.
(6)Specifies the purposes for which the information is collected.
(7)Specifies the length of time the authorization shall remain valid or describes an expiration event.
(8)Advises the person signing the authorization of the right to receive a copy of the authorization. Written authorization is required for each separate disclosure of the test results.
(h)This section shall not apply to disclosures required by the State Department of Health Services necessary to monitor compliance with Chapter 1 (commencing with Section 124975) of Part 5 of Division 106 of the Health and Safety Code, nor to disclosures required by the Department of Managed Health Care necessary to administer and enforce compliance with Section 1374.7 of the Health and Safety Code.
(i)For purposes of this section, genetic characteristic has the same meaning as that set forth in subdivision (d) of Section 1374.7 of the Health and Safety Code.
(j)For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement end of the research study, none, or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository
SEC. 3.Section 56.21 of the Civil Code is amended to read:56.21.An authorization for an employer to disclose medical information shall be valid if it complies with all of the following:
(a)Is handwritten or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization.
(c)Is signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)The patient, except that a patient who is a minor may only sign an authorization for the disclosure of medical information obtained by a provider of health care in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60) of Division 1.
(2)The legal representative of the patient, if the patient is a minor or incompetent. However, authorization may not be given under this subdivision for the disclosure of medical information that pertains to a competent minor and that was created by a provider of health care in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60) of Division 1.
(3)The beneficiary or personal representative of a deceased patient.
(d)States the limitations, if any, on the types of medical information to be disclosed.
(e)States the name or functions of the employer or person authorized to disclose the medical information.
(f)States the names or functions of the persons or entities authorized to receive the medical information.
(g)States the limitations, if any, on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States a specific date or expiration event after which the employer is no longer authorized to disclose the medical information.
(i)Advises the person who signed the authorization of the right to receive a copy of the authorization.
(j)For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement end of the research study, none, or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository
SEC. 4.Section 1633.3 of the Civil Code is amended to read:1633.3.(a)Except as otherwise provided in subdivisions (b) and (c), this title applies to electronic records and electronic signatures relating to a transaction.
(b)This title does not apply to transactions subject to any of the following laws:
(1)A law governing the creation and execution of wills, codicils, or testamentary trusts.
(2)Division 1 (commencing with Section 1101) of the Uniform Commercial Code, except Sections 1206 and 1306.
(3)Divisions 3 (commencing with Section 3101), 4 (commencing with Section 4101), 5 (commencing with Section 5101), 8 (commencing with Section 8101), 9 (commencing with Section 9101), and 11 (commencing with Section 11101) of the Uniform Commercial Code.
(4)A law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed, including initialed, from the record. However, this paragraph does not apply to Section 1677 or 1678 of this code or Section 1298 of the Code of Civil Procedure.
(c)This title does not apply to any specific transaction described in Section 17511.5 of the Business and Professions Code, Section 798.14, 1133, or 1134 of, Section 1689.6, 1689.7, or 1689.13 of, Chapter 2.5 (commencing with Section 1695) of Title 5 of Part 2 of Division 3 of, Section 1720, 1785.15, 1789.14, 1789.16, or 1793.23 of, Chapter 1 (commencing with Section 1801) of Title 2 of Part 4 of Division 3 of, Section 1861.24, 1862.5, 1917.712, 1917.713, 1950.6, 1983, 2924b, 2924c, 2924f, 2924i, 2924j, 2924.3, or 2937 of, Article 1.5 (commencing with Section 2945) of Chapter 2 of Title 14 of Part 4 of Division 3 of, Section 2954.5 or 2963 of, Chapter 2b (commencing with Section 2981) or 2d (commencing with Section 2985.7) of Title 14 of Part 4 of Division 3 of, Section 3071.5 of, Part 5 (commencing with Section 4000) of Division 4 of, or Part 5.3 (commencing with Section 6500) of Division 4 of, this code, subdivision (b) of Section 18608 or Section 22328 of the Financial Code, Section 1358.15, 1365, 1368.01, 1368.1, 1371, or 18035.5 of the Health and Safety Code, Section 786 as it applies to individual and group disability policies, 10199.44, 10199.46, 10235.16, 10235.40, 11624.09, or 11624.1 of the Insurance Code, Section 779.1, 10010.1, or 16482 of the Public Utilities Code, or Section 9975 or 11738 of the Vehicle Code. An electronic record may not be substituted for any notice that is required to be sent pursuant to Section 1162 of the Code of Civil Procedure. This subdivision does not prohibit the recordation of any document with a county recorder by electronic means.
(d)This title applies to an electronic record or electronic signature otherwise excluded from the application of this title under subdivision (b) when used for a transaction subject to a law other than those specified in subdivision (b).
(e)A transaction subject to this title is also subject to other applicable substantive law.
(f)The exclusion of a transaction from the application of this title under subdivision (b) or (c) shall be construed only to exclude the transaction from the application of this title, but shall not be construed to prohibit the transaction from being conducted by electronic means if the transaction may be conducted by electronic means under any other applicable law.
(g)Notwithstanding subdivisions (b) and (c), this title shall apply to electronic records and electronic signatures relating to transactions conducted by a person licensed, certified, or registered pursuant to the Alarm Company Act (Chapter 11.6 (commencing with Section 7590) of Division 3 of the Business and Professions Code) for purposes of activities authorized by Section 7599.54 of the Business and Professions Code.
Any person or entity that wishes to obtain medical information pursuant to subdivision (a) of Section 56.10, other than a person or entity authorized to receive medical information pursuant to subdivision (b) or (c) of Section 56.10, except as provided in paragraph (21) of subdivision (c) of Section 56.10, shall obtain a valid authorization for the release of this information.
An authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor shall be valid if it:
(a)Is handwritten by the person who signs it or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature which serves no other purpose than to execute the authorization.
(c)Is dated and bears signed, including with an electronic or handwritten signature signature, and dated by one of the following:
(1)The patient. A patient who is a minor may only sign an authorization for the release of medical information obtained by a provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60).
(2)The legal representative of the patient, if the patient is a minor or an incompetent. However, authorization may not be given under this subdivision for the disclosure of medical information obtained by the provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60).
(3)The spouse of the patient or the person financially responsible for the patient, where the medical information is being sought for the sole purpose of processing an application for health insurance or for enrollment in a nonprofit hospital plan, a health care service plan, or an employee benefit plan, and where the patient is to be an enrolled spouse or dependent under the policy or plan.
(4)The beneficiary or personal representative of a deceased patient.
(d)States the specific uses and limitations on the types of medical information to be disclosed.
(e)States the name or functions of the provider of health care, health care service plan, pharmaceutical company, or contractor that may disclose the medical information.
(f)States the name or functions of the persons or entities authorized to receive the medical information.
(g)States the specific uses and limitations on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States a specific date or expiration event after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(i)Advises the person signing the authorization of the right to receive a copy of the authorization.
SEC. 2.Section 56.17 of the Civil Code is amended to read:56.17.(a)This section shall apply to the disclosure of genetic test results contained in an applicants or enrollees medical records by a health care service plan.
(b)Any person who negligently discloses results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not to exceed one thousand dollars ($1,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(c)Any person who willfully discloses the results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not less than one thousand dollars ($1,000) and no more than five thousand dollars ($5,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(d)Any person who willfully or negligently discloses the results of a test for a genetic characteristic to a third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), that results in economic, bodily, or emotional harm to the subject of the test, is guilty of a misdemeanor punishable by a fine not to exceed ten thousand dollars ($10,000).
(e)In addition to the penalties listed in subdivisions (b) and (c), any person who commits any act described in subdivision (b) or (c) shall be liable to the subject for all actual damages, including damages for economic, bodily, or emotional harm which is proximately caused by the act.
(f)Each disclosure made in violation of this section is a separate and actionable offense.
(g)The applicants written authorization, as used in this section, shall satisfy the following requirements:
(1)Is written in plain language and is in a typeface no smaller than 14-point type.
(2)Is dated and bears signed, including with an electronic or handwritten signature signature, by the individual or a person authorized to act on behalf of the individual.
(3)Specifies the types of persons authorized to disclose information about the individual.
(4)Specifies the nature of the information authorized to be disclosed.
(5)States the name or functions of the persons or entities authorized to receive the information.
(6)Specifies the purposes for which the information is collected.
(7)Specifies the length of time the authorization shall remain valid. valid or describes an expiration event.
(8)Advises the person signing the authorization of the right to receive a copy of the authorization. Written authorization is required for each separate disclosure of the test results.
(h)This section shall not apply to disclosures required by the State Department of Health Services necessary to monitor compliance with Chapter 1 (commencing with Section 124975) of Part 5 of Division 106 of the Health and Safety Code, nor to disclosures required by the Department of Managed Health Care necessary to administer and enforce compliance with Section 1374.7 of the Health and Safety Code.
(i)For purposes of this section, genetic characteristic has the same meaning as that set forth in subdivision (d) of Section 1374.7 of the Health and Safety Code.
SEC. 3.Section 56.21 of the Civil Code is amended to read:56.21.An authorization for an employer to disclose medical information shall be valid if it complies with all of the following:
(a)Is handwritten by the person who signs it or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization.
(c)Is signed signed, including with an electronic or handwritten signature, and dated by one of the following:
(1)The patient, except that a patient who is a minor may only sign an authorization for the disclosure of medical information obtained by a provider of health care in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60) of Division 1.
(2)The legal representative of the patient, if the patient is a minor or incompetent. However, authorization may not be given under this subdivision for the disclosure of medical information that pertains to a competent minor and that was created by a provider of health care in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60) of Division 1.
(3)The beneficiary or personal representative of a deceased patient.
(d)States the limitations, if any, on the types of medical information to be disclosed.
(e)States the name or functions of the employer or person authorized to disclose the medical information.
(f)States the names or functions of the persons or entities authorized to receive the medical information.
(g)States the limitations, if any, on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States a specific date or expiration event after which the employer is no longer authorized to disclose the medical information.
(i)Advises the person who signed the authorization of the right to receive a copy of the authorization.
SEC. 3.SEC. 4.Section 1633.3 of the Civil Code is amended to read:1633.3.(a)Except as otherwise provided in subdivisions (b) and (c), this title applies to electronic records and electronic signatures relating to a transaction.
(b)This title does not apply to transactions subject to any of the following laws:
(1)A law governing the creation and execution of wills, codicils, or testamentary trusts.
(2)Division 1 (commencing with Section 1101) of the Uniform Commercial Code, except Sections 1206 and 1306.
(3)Divisions 3 (commencing with Section 3101), 4 (commencing with Section 4101), 5 (commencing with Section 5101), 8 (commencing with Section 8101), 9 (commencing with Section 9101), and 11 (commencing with Section 11101) of the Uniform Commercial Code.
(4)A law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed, including initialed, from the record. However, this paragraph does not apply to Section 1677 or 1678 of this code or Section 1298 of the Code of Civil Procedure.
(c)This title does not apply to any specific transaction described in Section 17511.5 of the Business and Professions Code, Section 798.14, 1133, or 1134 of, Section 1689.6, 1689.7, or 1689.13 of, Chapter 2.5 (commencing with Section 1695) of Title 5 of Part 2 of Division 3 of, Section 1720, 1785.15, 1789.14, 1789.16, or 1793.23 of, Chapter 1 (commencing with Section 1801) of Title 2 of Part 4 of Division 3 of, Section 1861.24, 1862.5, 1917.712, 1917.713, 1950.6, 1983, 2924b, 2924c, 2924f, 2924i, 2924j, 2924.3, or 2937 of, Article 1.5 (commencing with Section 2945) of Chapter 2 of Title 14 of Part 4 of Division 3 of, Section 2954.5 or 2963 of, Chapter 2b (commencing with Section 2981) or 2d (commencing with Section 2985.7) of Title 14 of Part 4 of Division 3 of, Section 3071.5 of, Part 5 (commencing with Section 4000) of Division 4 of, or Part 5.3 (commencing with Section 6500) of Division 4 of, this code, subdivision (b) of Section 18608 or Section 22328 of the Financial Code, Section 1358.15, 1365, 1368.01, 1368.1, 1371, or 18035.5 of the Health and Safety Code, Section 786 as it applies to individual and group disability policies, 10199.44, 10199.46, 10235.16, 10235.40, 11624.09, or 11624.1 of the Insurance Code, Section 779.1, 10010.1, or 16482 of the Public Utilities Code, or Section 9975 or 11738 of the Vehicle Code. An electronic record may not be substituted for any notice that is required to be sent pursuant to Section 1162 of the Code of Civil Procedure. This subdivision does not prohibit the recordation of any document with a county recorder by electronic means.
(d)This title applies to an electronic record or electronic signature otherwise excluded from the application of this title under subdivision (b) when used for a transaction subject to a law other than those specified in subdivision (b).
(e)A transaction subject to this title is also subject to other applicable substantive law.
(f)The exclusion of a transaction from the application of this title under subdivision (b) or (c) shall be construed only to exclude the transaction from the application of this title, but shall not be construed to prohibit the transaction from being conducted by electronic means if the transaction may be conducted by electronic means under any other applicable law.
(g)Notwithstanding subdivisions (b) and (c), this title shall apply to electronic records and electronic signatures relating to transactions conducted by a person licensed, certified, or registered pursuant to the Alarm Company Act (Chapter 11.6 (commencing with Section 7590) of Division 3 of the Business and Professions Code) for purposes of activities authorized by Section 7599.54 of the Business and Professions Code.
Any person or entity that wishes to obtain medical information pursuant to subdivision (a) of Section 56.10, other than a person or entity authorized to receive medical information pursuant to subdivision (b) or (c) of Section 56.10, except as provided in paragraph (21) of subdivision (c) of Section 56.10, shall obtain a valid authorization for the release of this information.
An authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor shall be valid if it:
(a)Is handwritten by the person who signs it or is in a typeface no smaller than 14-point type.
(b)Is clearly separate from any other language present on the same page and is executed by a signature which serves no other purpose than to execute the authorization.
(c)Is signed and dated Is dated and bears an electronic or handwritten signature by one of the following:
(1)The patient. A patient who is a minor may only sign an authorization for the release of medical information obtained by a provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which the minor could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60).
(2)The legal representative of the patient, if the patient is a minor or an incompetent. However, authorization may not be given under this subdivision for the disclosure of medical information obtained by the provider of health care, health care service plan, pharmaceutical company, or contractor in the course of furnishing services to which a minor patient could lawfully have consented under Part 1 (commencing with Section 25) or Part 2.7 (commencing with Section 60).
(3)The spouse of the patient or the person financially responsible for the patient, where the medical information is being sought for the sole purpose of processing an application for health insurance or for enrollment in a nonprofit hospital plan, a health care service plan, or an employee benefit plan, and where the patient is to be an enrolled spouse or dependent under the policy or plan.
(4)The beneficiary or personal representative of a deceased patient.
(d)States the specific uses and limitations on the types of medical information to be disclosed.
(e)States the name or functions of the provider of health care, health care service plan, pharmaceutical company, or contractor that may disclose the medical information.
(f)States the name or functions of the persons or entities authorized to receive the medical information.
(g)States the specific uses and limitations on the use of the medical information by the persons or entities authorized to receive the medical information.
(h)States a specific date after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information.
(i)Advises the person signing the authorization of the right to receive a copy of the authorization.
SEC. 2.Section 56.17 of the Civil Code is amended to read:56.17.(a)This section shall apply to the disclosure of genetic test results contained in an applicants or enrollees medical records by a health care service plan.
(b)Any person who negligently discloses results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not to exceed one thousand dollars ($1,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(c)Any person who willfully discloses the results of a test for a genetic characteristic to any third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), shall be assessed a civil penalty in an amount not less than one thousand dollars ($1,000) and no more than five thousand dollars ($5,000) plus court costs, as determined by the court, which penalty and costs shall be paid to the subject of the test.
(d)Any person who willfully or negligently discloses the results of a test for a genetic characteristic to a third party in a manner that identifies or provides identifying characteristics of the person to whom the test results apply, except pursuant to a written authorization as described in subdivision (g), that results in economic, bodily, or emotional harm to the subject of the test, is guilty of a misdemeanor punishable by a fine not to exceed ten thousand dollars ($10,000).
(e)In addition to the penalties listed in subdivisions (b) and (c), any person who commits any act described in subdivision (b) or (c) shall be liable to the subject for all actual damages, including damages for economic, bodily, or emotional harm which is proximately caused by the act.
(f)Each disclosure made in violation of this section is a separate and actionable offense.
(g)The applicants written authorization, as used in this section, shall satisfy the following requirements:
(1)Is written in plain language and is in a typeface no smaller than 14-point type.
(2)Is dated and signed Is dated and bears an electronic or handwritten signature by the individual or a person authorized to act on behalf of the individual.
(3)Specifies the types of persons authorized to disclose information about the individual.
(4)Specifies the nature of the information authorized to be disclosed.
(5)States the name or functions of the persons or entities authorized to receive the information.
(6)Specifies the purposes for which the information is collected.
(7)Specifies the length of time the authorization shall remain valid.
(8)Advises the person signing the authorization of the right to receive a copy of the authorization. Written authorization is required for each separate disclosure of the test results.
(h)This section shall not apply to disclosures required by the Department of Health Services necessary to monitor compliance with Chapter 1 (commencing with Section 124975) of Part 5 of Division 106 of the Health and Safety Code, nor to disclosures required by the Department of Managed Care necessary to administer and enforce compliance with Section 1374.7 of the Health and Safety Code.
(i)For purposes of this section, genetic characteristic has the same meaning as that set forth in subdivision (d) of Section 1374.7 of the Health and Safety Code.
SECTION 1.SEC. 3.Section 1633.3 of the Civil Code is amended to read:1633.3.(a)Except as otherwise provided in subdivisions (b) and (c), this title applies to electronic records and electronic signatures relating to a transaction.
(b)This title does not apply to transactions subject to any of the following laws:
(1)A law governing the creation and execution of wills, codicils, or testamentary trusts.
(2)Division 1 (commencing with Section 1101) of the Uniform Commercial Code, except Sections 1206 and 1306.
(3)Divisions 3 (commencing with Section 3101), 4 (commencing with Section 4101), 5 (commencing with Section 5101), 8 (commencing with Section 8101), 9 (commencing with Section 9101), and 11 (commencing with Section 11101) of the Uniform Commercial Code.
(4)A law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed, including initialed, from the record. However, this paragraph does not apply to Section 1677 or 1678 of this code or Section 1298 of the Code of Civil Procedure.
(c)This title does not apply to any specific transaction described in Section 17511.5 of the Business and Professions Code, Section 798.14, 1133, or 1134 of, Section 1689.6, 1689.7, or 1689.13 of, Chapter 2.5 (commencing with Section 1695) of Title 5 of Part 2 of Division 3 of, Section 1720, 1785.15, 1789.14, 1789.16, or 1793.23 of, Chapter 1 (commencing with Section 1801) of Title 2 of Part 4 of Division 3 of, Section 1861.24, 1862.5, 1917.712, 1917.713, 1950.6, 1983, 2924b, 2924c, 2924f, 2924i, 2924j, 2924.3, or 2937 of, Article 1.5 (commencing with Section 2945) of Chapter 2 of Title 14 of Part 4 of Division 3 of, Section 2954.5 or 2963 of, Chapter 2b (commencing with Section 2981) or 2d (commencing with Section 2985.7) of Title 14 of Part 4 of Division 3 of, Section 3071.5 of, Part 5 (commencing with Section 4000) of Division 4 of, or Part 5.3 (commencing with Section 6500) of Division 4 of, this code, subdivision (b) of Section 18608 or Section 22328 of the Financial Code, Section 1358.15, 1365, 1368.01, 1368.1, 1371, or 18035.5 of the Health and Safety Code, Section 786 as it applies to individual and group disability policies, 10199.44, 10199.46, 10235.16, 10235.40, 11624.09, or 11624.1 of the Insurance Code, Section 779.1, 10010.1, or 16482 of the Public Utilities Code, or Section 9975 or 11738 of the Vehicle Code. An electronic record may not be substituted for any notice that is required to be sent pursuant to Section 1162 of the Code of Civil Procedure. This subdivision does not prohibit the recordation of any document with a county recorder by electronic means.
(d)This title applies to an electronic record or electronic signature otherwise excluded from the application of this title under subdivision (b) when used for a transaction subject to a law other than those specified in subdivision (b).
(e)A transaction subject to this title is also subject to other applicable substantive law.
(f)The exclusion of a transaction from the application of this title under subdivision (b) or (c) shall be construed only to exclude the transaction from the application of this title, but shall not be construed to prohibit the transaction from being conducted by electronic means if the transaction may be conducted by electronic means under any other applicable law.
(g)Notwithstanding subdivisions (b) and (c), this title shall apply to electronic records and electronic signatures relating to transactions conducted by a person licensed, certified, or registered pursuant to the Alarm Company Act (Chapter 11.6 (commencing with Section 7590) of Division 3 of the Business and Professions Code) for purposes of activities authorized by Section 7599.54 of the Business and Professions Code.
(a)Except as otherwise provided in subdivisions (b) and (c), this title applies to electronic records and electronic signatures relating to a transaction.
(b)This title does not apply to transactions subject to any of the following laws:
(1)A law governing the creation and execution of wills, codicils, or testamentary trusts.
(2)Division 1 (commencing with Section 1101) of the Uniform Commercial Code, except Sections 1206 and 1306.
(3)Divisions 3 (commencing with Section 3101), 4 (commencing with Section 4101), 5 (commencing with Section 5101), 8 (commencing with Section 8101), 9 (commencing with Section 9101), and 11 (commencing with Section 11101) of the Uniform Commercial Code.
(4)A law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed, including initialed, from the record. However, this paragraph does not apply to Section 1677 or 1678 of this code or Section 1298 of the Code of Civil Procedure.
(c)This title does not apply to any specific transaction described in Section 17511.5 of the Business and Professions Code, Section 56.11, 56.17, 798.14, 1133, or 1134 of, Section 1689.6, 1689.7, or 1689.13 of, Chapter 2.5 (commencing with Section 1695) of Title 5 of Part 2 of Division 3 of, Section 1720, 1785.15, 1789.14, 1789.16, or 1793.23 of, Chapter 1 (commencing with Section 1801) of Title 2 of Part 4 of Division 3 of, Section 1861.24, 1862.5, 1917.712, 1917.713, 1950.6, 1983, 2924b, 2924c, 2924f, 2924i, 2924j, 2924.3, or 2937 of, Article 1.5 (commencing with Section 2945) of Chapter 2 of Title 14 of Part 4 of Division 3 of, Section 2954.5 or 2963 of, Chapter 2b (commencing with Section 2981) or 2d (commencing with Section 2985.7) of Title 14 of Part 4 of Division 3 of, Section 3071.5 of, Part 5 (commencing with Section 4000) of Division 4 of, or Part 5.3 (commencing with Section 6500) of Division 4 of, this code, subdivision (b) of Section 18608 or Section 22328 of the Financial Code, Section 1358.15, 1365, 1368.01, 1368.1, 1371, or 18035.5 of the Health and Safety Code, Section 786 as it applies to individual and group disability policies, 10199.44, 10199.46, 10235.16, 10235.40, 11624.09, or 11624.1 of the Insurance Code, Section 779.1, 10010.1, or 16482 of the Public Utilities Code, or Section 9975 or 11738 of the Vehicle Code. An electronic record may not be substituted for any notice that is required to be sent pursuant to Section 1162 of the Code of Civil Procedure. This subdivision does not prohibit the recordation of any document with a county recorder by electronic means.
(d)This title applies to an electronic record or electronic signature otherwise excluded from the application of this title under subdivision (b) when used for a transaction subject to a law other than those specified in subdivision (b).
(e)A transaction subject to this title is also subject to other applicable substantive law.
(f)The exclusion of a transaction from the application of this title under subdivision (b) or (c) shall be construed only to exclude the transaction from the application of this title, but shall not be construed to prohibit the transaction from being conducted by electronic means if the transaction may be conducted by electronic means under any other applicable law.
(g)Notwithstanding subdivisions (b) and (c), this title shall apply to electronic records and electronic signatures relating to transactions conducted by a person licensed, certified, or registered pursuant to the Alarm Company Act (Chapter 11.6 (commencing with Section 7590) of Division 3 of the Business and Professions Code) for purposes of activities authorized by Section 7599.54 of the Business and Professions Code.
|
Date
|
Status
|
|---|---|
| Oct 7, 2023 | Chaptered by Secretary of State - Chapter 374, Statutes of 2023. |
| Oct 7, 2023 | Approved by the Governor. |
| Sep 13, 2023 | Enrolled and presented to the Governor at 3 p.m. |
| Sep 7, 2023 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 79. Noes 0. Page 3045.). |
| Sep 7, 2023 | Assembly Rule 77 suspended. (Page 3011.) |
| Sep 6, 2023 | In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 8 pursuant to Assembly Rule 77. |
| Sep 6, 2023 | Read third time. Passed. Ordered to the Assembly. (Ayes 40. Noes 0. Page 2399.). |
| Aug 30, 2023 | Read second time. Ordered to third reading. |
| Aug 29, 2023 | Read third time and amended. Ordered to second reading. |
| Jul 13, 2023 | Ordered to third reading. |
| Jul 13, 2023 | From Consent Calendar. |
| Jul 10, 2023 | Read second time and amended. Ordered to consent calendar. |
| Jul 6, 2023 | From committee: Amend, and do pass as amended. To Consent Calendar. (Ayes 11. Noes 0.) (July 6). |
| May 17, 2023 | Referred to Com. on JUD. |
| May 4, 2023 | In Senate. Read first time. To Com. on RLS. for assignment. |
| May 4, 2023 | Read third time. Passed. Ordered to the Senate. (Ayes 75. Noes 0. Page 1466.) |
| May 1, 2023 | Read second time. Ordered to Consent Calendar. |
| Apr 27, 2023 | Read second time and amended. Ordered returned to second reading. |
| Apr 26, 2023 | From committee: Amend, and do pass as amended. To Consent Calendar. (Ayes 11. Noes 0.) (April 25). |
| Apr 7, 2023 | Re-referred to Com. on P. & C.P. |
| Apr 6, 2023 | From committee chair, with author's amendments: Amend, and re-refer to Com. on P. & C.P. Read second time and amended. |
| Mar 15, 2023 | Re-referred to Com. on P. & C.P. |
| Mar 14, 2023 | From committee chair, with author's amendments: Amend, and re-refer to Com. on P. & C.P. Read second time and amended. |
| Mar 9, 2023 | Referred to Com. on P. & C.P. |
| Feb 18, 2023 | From printer. May be heard in committee March 20. |
| Feb 17, 2023 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Sep 7, 2023 | AB 1697 Schiavo Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Sep 6, 2023 | Assembly 3rd Reading AB1697 Schiavo By Stern | Senate Floor |
Passed |
|
| Jul 6, 2023 | Do pass as amended, and be ordered to the Consent Calendar | Senate Standing Committee on Judiciary |
Passed |
|
| May 4, 2023 | AB 1697 Schiavo Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Apr 25, 2023 | Do pass as amended. To Consent Calendar. | Assembly Standing Committee on Privacy and Consumer Protection |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| California Dental Association | ** Support |
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 1697
Author:(Schiavo)
As Amended Ver:August 29, 2023
Majority vote
SUMMARY
Permits use of electronic signatures to authorize disclosure of medical information and genetic test results. Permits these authorizations to expire on the occurrence of a specified date or event.
Major Provisions
- Deems any of the following authorizations—(i) for release of medical information, by a provider of health care, health care service plan, pharmaceutical company, or contractor; (ii) for disclosure of genetic test results contained in an applicant’s or enrollee’s medical records, by a health care service plan; (iii) for an employer to disclose medical information—to be valid if, among other enumerated requirements, the authorization:
- Is signed, even if signed with an electronic signature.
- States an expiration date or event.
Allows the authorization of (i) and (iii) to be handwritten, even if not by the person signing.
- Defines “expiration date or event” as a specified date or occurrence after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information. The date or event must relate to the individual to whom the information pertains or to the purpose of the use or disclosure.
- Requires the expiration date or event to limit the duration of the authorization to one year or less, unless the signer requests a specific date beyond a year. If the authorization is for a clinical trial or medical research study, the expiration date or event can extend beyond one year, but not longer than the completion of the trial or study.
- Requires an entity seeking authorization for use or disclosure of protected health information to provide the signer with a copy of the signed authorization, and instructions on how to access additional copies or a digital version of the signed authorization.
- Amends California's Uniform Electronic Transactions Act so that it no longer excludes (i) electronic signatures for authorizations for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and (ii) authorizations for the release of genetic test results by a health care service plan, thereby authorizing the use of electronic contracts and electronic signatures for both.
Senate Amendments
Elaborate on the conditions for specifying an expiration date or event; provide for signers to receive copies of signed authorizations; ensure accurate cross-references for Code sections addressing provision of consent by legal representatives of minors and persons who lack capacity, and of beneficiaries or personal representatives of deceased patients; address potential chaptering issues with AB 254 (Bauer-Kahan).
COMMENTS
California's Uniform Electronic Transactions Act (UETA), enacted in 1999, generally recognizes that digital documents signed electronically have the same legal efficacy and validity as printed documents that are signed by hand. However, due to concerns around fraud and meaningful consent, certain documents and transactions are categorically excluded from UETA and must have a "wet ink" signature. Examples of such excluded documents and transactions are wills, automobile sales and lease contracts, and the subject of this bill: (i) authorizations for release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor; and (ii) authorizations for release of genetic test results by a health service plan. (See, generally, Civil Code Section 1633.3(b), (c).) California's Confidentiality of Medical Information Act (CMIA) also imposes a handwritten signature requirement on both of these types of documents, as well as on authorizations for an employer to release medical information.
The premise of this bill is that California's prohibition on e-signatures for these three categories of documents is unduly burdensome for patients, given that telemedicine is increasingly becoming the norm for provision of health care services where in-person contact is not required. Accordingly, the bill would permit e-signatures on all three categories of documents.
If enacted, this bill could prove relevant in implementing California's Health and Human Services Data Exchange Framework, described as:
[A] first-ever, statewide data sharing agreement that will accelerate and expand the exchange of health information among health care entities, government agencies, and social service programs beginning in 2024. The data exchange framework is…an agreement across health and human services systems and providers to share information safely. That means every health care provider can access the information they need to treat you quickly and safely; health care, behavioral health and social services agencies can connect to each other to deliver what Californians need to be healthy; and our public health system can better assess how to address the needs of all communities. (Center for Data Insights and Innovations, What is the Data Exchange Framework?, available at [https://www.cdii.ca.gov/committees-and-advisory-groups/data-exchange-framework/].)
The bill also proposes to add flexibility to authorizations for release of medical information by allowing them to expire when a specified event occurs (rather than on a specified date) and by allowing them to be handwritten by persons other than the signatory (thereby assisting persons with certain disabilities.)
Finally, the bill requires an entity that seeks authorization for use or disclosure of protected health information to provide the signer with a copy of the signed authorization, and instructions on how to access additional copies or a digital version.
According to the Author
AB 1697 will reduce administrative barriers patients face in authorizing medical providers to share their medical history. As transactions have increasingly occurred online, and as digital security has expanded to support legally binding electronic signatures, electronic signatures are becoming a secure and commonplace method of providing an individual's legal authorization. With the advent of remote work and telehealth, allowing electronic signatures for medical release forms is an opportunity to reduce administrative barriers for patients. AB 1697 does so by ensuring that electronic signatures are given equal legal [status as] physical signatures.
Arguments in Support
California Dental Association writes:
The use of telehealth services has significantly increased since the onset of the COVID-19 pandemic, which has included dentistry. As access to oral health through the use of teledentistry becomes more readily available, as in other areas of medicine, so should the availability of patient's ability to use electronic signatures. Without updating existing law, patients may be able to receive critical and much needed care remotely, but then face barriers on the administrative side, having to either go in person or mail release forms back to their providers. AB 1697 will reduce administrative barriers for patients while continuing to protect patients through HIPAA.
Arguments in Opposition
None received.
FISCAL COMMENTS
None.
VOTES:
ASM PRIVACY AND CONSUMER PROTECTION: 11-0-0
YES: Gabriel, Joe Patterson, Bauer-Kahan, Bennett, Essayli, Vince Fong, Irwin, Lowenthal, Papan, Wicks, Wilson
ASSEMBLY FLOOR: 75-0-5
YES: Addis, Aguiar-Curry, Alanis, Alvarez, Arambula, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Chen, Connolly, Megan Dahle, Davies, Dixon, Essayli, Mike Fong, Vince Fong, Friedman, Gabriel, Gallagher, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lackey, Lee, Low, Lowenthal, Maienschein, Mathis, McCarty, Stephanie Nguyen, Ortega, Pacheco, Papan, Jim Patterson, Joe Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Ward, Weber, Wilson, Wood, Zbur, Rendon
ABS, ABST OR NV: Flora, McKinnor, Muratsuchi, Wallis, Wicks
SENATE FLOOR: 40-0-0
YES: Allen, Alvarado-Gil, Archuleta, Ashby, Atkins, Becker, Blakespear, Bradford, Caballero, Cortese, Dahle, Dodd, Durazo, Eggman, Glazer, Gonzalez, Grove, Hurtado, Jones, Laird, Limón, McGuire, Menjivar, Min, Newman, Nguyen, Niello, Ochoa Bogh, Padilla, Portantino, Roth, Rubio, Seyarto, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener, Wilk
UPDATED
VERSION: August 29, 2023
CONSULTANT: Jith Meganathan / P. & C.P. / (916) 319-2200 FN: 0001913
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 1697 |
THIRD READING
Bill No: AB 1697
Author: Schiavo (D)
Amended: 8/29/23 in Senate
Vote: 21
SENATE JUDICIARY COMMITTEE: 11-0, 7/6/23
AYES: Umberg, Wilk, Allen, Ashby, Caballero, Durazo, Laird, Min, Niello, Stern, Wiener
ASSEMBLY FLOOR: 75-0, 5/4/23 (Consent) - See last page for vote
SUBJECT: Uniform Electronic Transactions Act
SOURCE: Author
DIGEST:
This bill removes the exemptions from the California Uniform Electronic Transactions Act for authorizations to release medical records and genetic test results. This bill amends the requirement that such authorizations have a specific end date, allowing for an “expiration event,” to be stated instead.
Senate Floor Amendments of 8/29/23 clarify the obligation to provide a copy of the signed authorization, allow for longer periods of authorization, and make technical amendments, including amendments to avoid chaptering out issues.
ANALYSIS:
Existing law:
- Establishes the Uniform Electronic Transactions Act (UETA), which generally authorizes the transaction of business, commerce, and contracts by electronic means. (Civ. Code § 1633.1 et seq.) UETA does not apply to transactions that are subject to certain laws, such as laws governing the creation and execution of wills, codicils, or testamentary trusts. (Civ. Code § 1633.3(a).)
- Provides a series of specific transactions to which UETA does not apply. Among these exemptions are authorizations for the release of medical information and authorizations for the disclosure of genetic test results. (Civ. Code § 1633.3(c).)
- Establishes, in federal law, the Electronic Signatures in Global and National Commerce Act (E-SIGN), which generally provides for the transmission of electronic signatures, but does not apply to a contract or other record that is governed by: (a) a statute, regulation, or other rule of law governing the creation and execution of wills, codicils, or testamentary trusts; (b) a state statute, regulation, or other rule of law governing adoption, divorce, or other matters of family law; or (c) the Uniform Commercial Code, as in effect in any State, as specified. (15 U.S.C. §§ 7001, 7003(a).)
- Excludes from the application of E-SIGN the following specific transactions: (a) court orders or notices, or official court documents (including briefs, pleadings, and other writings) required to be executed in connection with court proceedings; (b) any notice of (i) the cancellation or termination of utility services (including water, heat, and power), (ii) default, acceleration, repossession, foreclosure, or eviction, or the right to cure, under a credit agreement secured by, or a rental agreement for, a primary residence of an individual, (iii) the cancellation or termination of health insurance or benefits or life insurance benefits (excluding annuities), or (iv) recall of a product, or material failure of a product, that risks endangering health or safety; or (c) any document required to accompany any transportation or handling of hazardous materials, pesticides, or other toxic or dangerous materials. (15 U.S.C. § 7003(b).)
- Requires any person or entity that wishes to obtain medical information, as specified, to obtain a valid authorization for the release of this information. The release must be handwritten by the person who signs it or be in a typeface no smaller than 14-point type. It must be clearly separate from any other language present on the same page and be executed by a signature which serves no other purpose than to execute the authorization. It must be signed and dated by the patient or another legally authorized individual, as specified. The release must state a specific date after which the authority to disclose the medical information expires. (Civ. Code § 56.11.)
- Subjects a person who improperly discloses, as provided, genetic test results contained in an applicant’s or enrollee’s medical records without written authorization of the applicant to civil penalties, as specified. A valid written authorization must be written in plain language in typeface no smaller than 14-point type and be dated and signed by the individual or another authorized individual. It must further specify the length of the time the authorization remains valid. (Civ. Code § 56.17.)
- Provides that an authorization for an employer to disclose medical information shall be valid if it is handwritten by the person who signs it or is in a typeface no smaller than 14-point type; is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization; and is signed and dated by the patient or another legally authorized individual, as specified. The authorization must state a specific date after which the authority for the employer to disclose the medical information expires. (Civ. Code § 56.21.)
This bill:
- Deletes the exemptions for the above-described authorizations for release of medical information and genetic test results under the Confidentiality of Medical Information Act.
- Amends the requirement that such authorizations have a specific end date to allow for an “expiration date or event” to also suffice.
- Provides that an expiration event shall relate to the individual or the purpose of the use or disclosure. The expiration date or event shall limit the duration of the authorization to one year or less, unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study, or the person signing the authorization requests a specific date beyond a year.
- Requires the signatory to be provided a copy of the written authorization by the person or entity seeking the authorization, and instructions on how to access additional copies or a digital version, as provided.
Background
The California UETA generally authorizes the transaction of business, commerce, and contracts by electronic means. (Civ. Code § 1633.1.) UETA does not apply to transactions that are subject to certain laws, such as laws governing the creation and execution of wills, codicils, or testamentary trusts. (Civ. Code § 1633.3(a).) UETA further lists a series of specific transactions to which it does not apply. Among the transactions exempted are authorizations for the release of medical information and authorizations for the disclosure of genetic test results. (Civ. Code § 1633.3(c).) In order to authorize the sharing of such records, current law requires written signatures.
As the people of California increasingly turn to telehealth options and other remote means of communicating, this bill relaxes the current patient and consumer protections by removing the exemptions within UETA for such authorizations and allowing for electronic signatures to suffice for authorizations to release genetic test results and medical records, including by an employer. This bill also removes the current requirement that such authorizations must have a specific end date. Instead, it allows for an “expiration date or event” to suffice, as provided. Copies of the authorizations must be provided to the signatories.
This bill is sponsored by the author. It is supported by the California Dental Association. There is no known opposition.
Comments
Electronic transactions
In 1999, with the passage of SB 820 (Sher, Chapter 428, Statutes of 1999), California enacted UETA, which was based on a model law to set rules by which electronic commerce may be conducted across the country proposed by the National Conference of Commissioners on Uniform State Laws. One of the motivating factors for enacting a law validating electronic records was the Statute of Frauds, which requires that certain contracts be in writing. In California, the Statute of Frauds is codified at Section 1624 of the Civil Code, which expressly states that certain contracts are invalid (i.e., unenforceable) unless they, or some note or memorandum thereof, are in writing and subscribed by the party to be charged or by the party’s agent. Such contracts include, for example: an agreement that by its terms is not to be performed within a year from its making; an agreement for a lease lasting for a period longer than one year; an agreement for the sale of real property, or of an interest therein; or specified contracts, promises, undertakings, or commitments to loan money or to grant or extend credit, in an amount greater than $100,000.
Subsequent to UETA’s passage, E-SIGN was enacted at the federal level. E-SIGN generally provides for the transmission of electronic signatures, but contains a number of exemptions. However, it does allow for vehicle sales to be conducted electronically.
UETA provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form, that a contract may not be denied legal effect or enforceability solely because an electronic record was used in its formation, and that an electronic record or signature satisfies a requirement in the law that a record be in writing or a signature be affixed or if a law provides consequences if there is no record or signature.
UETA, however, does not apply to all contracts. For example, expressly excluded from UETA are: transactions that are subject to a law governing the creation and execution of wills, codicils, or testamentary trusts; specified transactions in the Uniform Commercial Code that were specifically drafted in consideration of electronic records; and transactions subject to a law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed or initialed, such as real estate transactions.
Allowing for electronic signatures in connection with authorizations to release specified information
Relevant here, written authorizations for the release of medical information from a provider of health care, health care service plan, pharmaceutical company, contractor, or employer and for the release of genetic test results contained in an applicant’s or enrollee’s medical records by a health care service plan are exempt from UETA.
This bill removes these exemptions allowing patients to authorize the release of their medical information and genetic test results through electronically signing such authorizations.
Given the rise of telehealth services, especially in the wake of the COVID-19 pandemic, it is arguably appropriate to allow for such releases to be executed by electronic signature. Removing these exemptions removes a barrier for patients seeking to provide the relevant authorizations. However, there is concern that with the move to electronically signing such authorizations, patients will be less aware of what exactly they are authorizing. To mitigate any concerns in this area, the bill requires copies of these authorizations to be provided to the signatories thereto by the person or entity seeking such authorization.
According to the author:
AB 1697 will reduce administrative barriers patients face in authorizing medical providers to share their medical history. As transactions have increasingly occurred online, and as digital security has expanded to support legally binding electronic signatures, electronic signatures are becoming a secure and commonplace method of providing an individual’s legal authorization. With the advent of remote work and telehealth, allowing electronic signatures for medical release forms is an opportunity to reduce administrative barriers for patients. AB 1697 does so by ensuring that electronic signatures are given equal legal to physical signatures.
Relaxing the requirement for a specified end date
Currently, the above authorizations all require a specified end date upon which the authority to release records by the specified person or entity ends. For instance, Section 56.11 of the Civil Code provides that an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor must state a specific date after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information. Section 56.21 imposes a similar requirement for an authorization for an employer to disclose medical information. Section 56.17 provides for specified penalties for improper disclosure of genetic test results contained in an applicant’s or enrollee’s medical records by a health care service plan. Such disclosures must be made pursuant to a written authorization by the applicant that specifies the length of time the authorization shall remain valid.
This bill amends these requirements by alternatively allowing for specification of an “expiration date or event” to instead suffice. Such event must relate to the individual or the purpose of the use or disclosure.
The purpose of the specified end date in current law is to protect the privacy of the signatories with respect to this incredibly sensitive personal information. The patient, enrollee, or applicant is also put on clear notice of how long the authorization will be in effect. To avoid a weakening of these protections, this bill provides a one-year maximum on the authorization, except as provided for clinical trials or research studies or if a date further than one year out is requested by the individual.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 8/29/23)
California Dental Association
OPPOSITION: (Verified 8/29/23)
None received
ARGUMENTS IN SUPPORT: The California Dental Association states:
The use of telehealth services has significantly increased since the onset of the COVID-19 pandemic, which has included dentistry. As access to oral health through the use of teledentistry becomes more readily available, as in other areas of medicine, so should the availability of patient’s ability to use electronic signatures. Without updating existing law, patients may be able to receive critical and much needed care remotely, but then face barriers on the administrative side, having to either go in person or mail release forms back to their providers. AB 1697 will reduce administrative barriers for patients while continuing to protect patients through HIPAA.
ASSEMBLY FLOOR: 75-0, 5/4/23
AYES: Addis, Aguiar-Curry, Alanis, Alvarez, Arambula, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Chen, Connolly, Megan Dahle, Davies, Dixon, Essayli, Mike Fong, Vince Fong, Friedman, Gabriel, Gallagher, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lackey, Lee, Low, Lowenthal, Maienschein, Mathis, McCarty, Stephanie Nguyen, Ortega, Pacheco, Papan, Jim Patterson, Joe Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Ward, Weber, Wilson, Wood, Zbur, Rendon
NO VOTE RECORDED: Flora, McKinnor, Muratsuchi, Wallis, Wicks
Prepared by: Christian Kurpiewski / JUD. / (916) 651-4113
8/31/23 11:08:01
**** END ****
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 1697 |
THIRD READING
Bill No: AB 1697
Author: Schiavo (D)
Amended: 7/10/23 in Senate
Vote: 21
SENATE JUDICIARY COMMITTEE: 11-0, 7/6/23
AYES: Umberg, Wilk, Allen, Ashby, Caballero, Durazo, Laird, Min, Niello, Stern, Wiener
ASSEMBLY FLOOR: 75-0, 5/4/23 (Consent) - See last page for vote
SUBJECT: Uniform Electronic Transactions Act
SOURCE: Author
DIGEST:
This bill removes the exemptions from the California Uniform Electronic Transactions Act for authorizations to release medical records and genetic test results. This bill amends the requirement that such authorizations have a specific end date, allowing for an “expiration event,” to be stated instead. This bill requires a copy of the authorization to be made available to the signatory thereto.
ANALYSIS:
Existing law:
- Establishes the Uniform Electronic Transactions Act (UETA), which generally authorizes the transaction of business, commerce, and contracts by electronic means. (Civ. Code § 1633.1 et seq.) UETA does not apply to transactions that are subject to certain laws, such as laws governing the creation and execution of wills, codicils, or testamentary trusts. (Civ. Code § 1633.3(a).)
- Provides a series of specific transactions to which UETA does not apply. Among these exemptions are authorizations for the release of medical information and authorizations for the disclosure of genetic test results. (Civ. Code § 1633.3(c).)
- Establishes, in federal law, the Electronic Signatures in Global and National Commerce Act (E-SIGN), which generally provides for the transmission of electronic signatures, but does not apply to a contract or other record that is governed by: (a) a statute, regulation, or other rule of law governing the creation and execution of wills, codicils, or testamentary trusts; (b) a state statute, regulation, or other rule of law governing adoption, divorce, or other matters of family law; or (c) the Uniform Commercial Code, as in effect in any State, as specified. (15 U.S.C. §§ 7001, 7003(a).)
- Excludes from the application of E-SIGN the following specific transactions: (a) court orders or notices, or official court documents (including briefs, pleadings, and other writings) required to be executed in connection with court proceedings; (b) any notice of (i) the cancellation or termination of utility services (including water, heat, and power), (ii) default, acceleration, repossession, foreclosure, or eviction, or the right to cure, under a credit agreement secured by, or a rental agreement for, a primary residence of an individual, (iii) the cancellation or termination of health insurance or benefits or life insurance benefits (excluding annuities), or (iv) recall of a product, or material failure of a product, that risks endangering health or safety; or (c) any document required to accompany any transportation or handling of hazardous materials, pesticides, or other toxic or dangerous materials. (15 U.S.C. § 7003(b).)
- Requires any person or entity that wishes to obtain medical information, as specified, to obtain a valid authorization for the release of this information. The release must be handwritten by the person who signs it or be in a typeface no smaller than 14-point type. It must be clearly separate from any other language present on the same page and be executed by a signature which serves no other purpose than to execute the authorization. It must be signed and dated by the patient or another legally authorized individual, as specified. The release must state a specific date after which the authority to disclose the medical information expires. (Civ. Code § 56.11.)
- Subjects a person who improperly discloses, as provided, genetic test results contained in an applicant’s or enrollee’s medical records without written authorization of the applicant to civil penalties, as specified. A valid written authorization must be written in plain language in typeface no smaller than 14-point type and be dated and signed by the individual or another authorized individual. It must further specify the length of the time the authorization remains valid. (Civ. Code § 56.17.)
- Provides that an authorization for an employer to disclose medical information shall be valid if it is handwritten by the person who signs it or is in a typeface no smaller than 14-point type; is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization; and is signed and dated by the patient or another legally authorized individual, as specified. The authorization must state a specific date after which the authority for the employer to disclose the medical information expires. (Civ. Code § 56.21.)
This bill:
- Deletes the exemptions for the above-described authorizations for release of medical information and genetic test results under the Confidentiality of Medical Information Act.
- Amends the requirement that such authorizations have a specific end date to allow for an “expiration date or event” to also suffice.
- Provides that an expiration event shall relate to the individual or the purpose of the use or disclosure. The expiration date or event shall limit the duration of the authorization to one year or less, unless the authorization is related to an approved clinical trial, as defined in Section 1370.6 of the Health and Safety Code, or medical research study, in which case the authorization may extend beyond one year if the expiration date or event extends no longer than the completion of the relevant clinical trial or research study.
- Requires the signatory to be provided a copy of the written authorization.
Background
The California UETA generally authorizes the transaction of business, commerce, and contracts by electronic means. (Civ. Code § 1633.1.) UETA does not apply to transactions that are subject to certain laws, such as laws governing the creation and execution of wills, codicils, or testamentary trusts. (Civ. Code § 1633.3(a).) UETA further lists a series of specific transactions to which it does not apply. Among the transactions exempted are authorizations for the release of medical information and authorizations for the disclosure of genetic test results. (Civ. Code § 1633.3(c).) In order to authorize the sharing of such records, current law requires written signatures.
As the people of California increasingly turn to telehealth options and other remote means of communicating, this bill relaxes the current patient and consumer protections by removing the exemptions within UETA for such authorizations and allowing for electronic signatures to suffice for authorizations to release genetic test results and medical records, including by an employer. This bill also removes the current requirement that such authorizations must have a specific end date. Instead, it allows for an “expiration date or event” to suffice, as provided. Copies of the authorizations must be provided to the signatories.
This bill is sponsored by the author. It is supported by the California Dental Association. There is no known opposition.
Comments
Electronic transactions
In 1999, with the passage of SB 820 (Sher, Chapter 428, Statutes of 1999), California enacted UETA, which was based on a model law to set rules by which electronic commerce may be conducted across the country proposed by the National Conference of Commissioners on Uniform State Laws. One of the motivating factors for enacting a law validating electronic records was the Statute of Frauds, which requires that certain contracts be in writing. In California, the Statute of Frauds is codified at Section 1624 of the Civil Code, which expressly states that certain contracts are invalid (i.e., unenforceable) unless they, or some note or memorandum thereof, are in writing and subscribed by the party to be charged or by the party’s agent. Such contracts include, for example: an agreement that by its terms is not to be performed within a year from its making; an agreement for a lease lasting for a period longer than one year; an agreement for the sale of real property, or of an interest therein; or specified contracts, promises, undertakings, or commitments to loan money or to grant or extend credit, in an amount greater than $100,000.
Subsequent to UETA’s passage, E-SIGN was enacted at the federal level. E-SIGN generally provides for the transmission of electronic signatures, but contains a number of exemptions. However, it does allow for vehicle sales to be conducted electronically.
UETA provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form, that a contract may not be denied legal effect or enforceability solely because an electronic record was used in its formation, and that an electronic record or signature satisfies a requirement in the law that a record be in writing or a signature be affixed or if a law provides consequences if there is no record or signature.
UETA, however, does not apply to all contracts. For example, expressly excluded from UETA are: transactions that are subject to a law governing the creation and execution of wills, codicils, or testamentary trusts; specified transactions in the Uniform Commercial Code that were specifically drafted in consideration of electronic records; and transactions subject to a law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed or initialed, such as real estate transactions.
Allowing for electronic signatures in connection with authorizations to release specified information
Relevant here, written authorizations for the release of medical information from a provider of health care, health care service plan, pharmaceutical company, contractor, or employer and for the release of genetic test results contained in an applicant’s or enrollee’s medical records by a health care service plan are exempt from UETA.
This bill removes these exemptions allowing patients to authorize the release of their medical information and genetic test results through electronically signing such authorizations.
Given the rise of telehealth services, especially in the wake of the COVID-19 pandemic, it is arguably appropriate to allow for such releases to be executed by electronic signature. Removing these exemptions removes a barrier for patients seeking to provide the relevant authorizations. However, there is concern that with the move to electronically signing such authorizations, patients will be less aware of what exactly they are authorizing. To mitigate any concerns in this area, the bill requires copies of these authorizations to be provided to the signatories thereto.
According to the author:
AB 1697 will reduce administrative barriers patients face in authorizing medical providers to share their medical history. As transactions have increasingly occurred online, and as digital security has expanded to support legally binding electronic signatures, electronic signatures are becoming a secure and commonplace method of providing an individual’s legal authorization. With the advent of remote work and telehealth, allowing electronic signatures for medical release forms is an opportunity to reduce administrative barriers for patients. AB 1697 does so by ensuring that electronic signatures are given equal legal to physical signatures.
Relaxing the requirement for a specified end date
Currently, the above authorizations all require a specified end date upon which the authority to release records by the specified person or entity ends. For instance, Section 56.11 of the Civil Code provides that an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor must state a specific date after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information. Section 56.21 imposes a similar requirement for an authorization for an employer to disclose medical information. Section 56.17 provides for specified penalties for improper disclosure of genetic test results contained in an applicant’s or enrollee’s medical records by a health care service plan. Such disclosures must be made pursuant to a written authorization by the applicant that specifies the length of time the authorization shall remain valid.
This bill amends these requirements by alternatively allowing for specification of an “expiration event” to instead suffice. Such event must relate to the individual or the purpose of the use or disclosure.
The purpose of the specified end date in current law is to protect the privacy of the signatories with respect to this incredibly sensitive personal information. The patient, enrollee, or applicant is also put on clear notice of how long the authorization will be in effect. To avoid a weakening of these protections, this bill provides a one-year maximum on the authorization, except as provided for clinical trials or research studies. In the latter cases, the expiration event may extend longer than one year, but in no event can it extend beyond the end of the relevant clinical trial or study.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
SUPPORT: (Verified 7/10/23)
California Dental Association
OPPOSITION: (Verified 7/10/23)
None received
ARGUMENTS IN SUPPORT: The California Dental Association states:
The use of telehealth services has significantly increased since the onset of the COVID-19 pandemic, which has included dentistry. As access to oral health through the use of teledentistry becomes more readily available, as in other areas of medicine, so should the availability of patient’s ability to use electronic signatures. Without updating existing law, patients may be able to receive critical and much needed care remotely, but then face barriers on the administrative side, having to either go in person or mail release forms back to their providers. AB 1697 will reduce administrative barriers for patients while continuing to protect patients through HIPAA.
ASSEMBLY FLOOR: 75-0, 5/4/23
AYES: Addis, Aguiar-Curry, Alanis, Alvarez, Arambula, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Chen, Connolly, Megan Dahle, Davies, Dixon, Essayli, Mike Fong, Vince Fong, Friedman, Gabriel, Gallagher, Garcia, Gipson, Grayson, Haney, Hart, Holden, Hoover, Irwin, Jackson, Jones-Sawyer, Kalra, Lackey, Lee, Low, Lowenthal, Maienschein, Mathis, McCarty, Stephanie Nguyen, Ortega, Pacheco, Papan, Jim Patterson, Joe Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Sanchez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Ward, Weber, Wilson, Wood, Zbur, Rendon
NO VOTE RECORDED: Flora, McKinnor, Muratsuchi, Wallis, Wicks
Prepared by: Christian Kurpiewski / JUD. / (916) 651-4113
7/13/23 11:47:30
**** END ****
Senator Thomas Umberg, Chair
2023-2024 Regular Session
Bill No: AB 1697 (Author:Schiavo)
Version: April 27, 2023
Hearing Date: July 6, 2023
Fiscal: No
Urgency: No
Consultant: CK
SUBJECT
Uniform Electronic Transactions Act
DIGEST
This bill removes the exemptions from the California Uniform Electronic Transactions Act for authorizations to release medical records and genetic test results. The bill amends the requirement that such authorizations have a specific end date, allowing for an “expiration event,” to be stated instead.
EXECUTIVE SUMMARY
The California Uniform Electronic Transactions Act (UETA) generally authorizes the transaction of business, commerce, and contracts by electronic means. (Civ. Code § 1633.1.) UETA does not apply to transactions that are subject to certain laws, such as laws governing the creation and execution of wills, codicils, or testamentary trusts. (Civ. Code § 1633.3(a).) UETA further lists a series of specific transactions to which it does not apply. Among the transactions exempted are authorizations for the release of medical information and authorizations for the disclosure of genetic test results. (Civ. Code § 1633.3(c).) In order to authorize the sharing of such records, current law requires written signatures.
As the people of California increasingly turn to telehealth options and other remote means of communicating, this bill relaxes the current patient and consumer protections by removing the exemptions within UETA for such authorizations and allowing for electronic signatures to suffice for authorizations to release genetic test results and medical records, including by an employer. The bill also removes the current requirement that such authorizations must have a specific end date. Instead, it allows for an “expiration event” to suffice.
The bill is sponsored by the author. It is supported by the California Dental Association. There is no known opposition.
PROPOSED CHANGES TO THE LAW
Existing law:
- Establishes the Uniform Electronic Transactions Act (UETA), which generally authorizes the transaction of business, commerce, and contracts by electronic means. (Civ. Code § 1633.1 et seq.) UETA does not apply to transactions that are subject to certain laws, such as laws governing the creation and execution of wills, codicils, or testamentary trusts. (Civ. Code § 1633.3(a).)
- Provides a series of specific transactions to which UETA does not apply. Among these exemptions are authorizations for the release of medical information and authorizations for the disclosure of genetic test results. (Civ. Code § 1633.3(c).)
- Establishes, in federal law, the Electronic Signatures in Global and National Commerce Act (E-SIGN), which generally provides for the transmission of electronic signatures, but does not apply to a contract or other record that is governed by: (1) a statute, regulation, or other rule of law governing the creation and execution of wills, codicils, or testamentary trusts; (2) a state statute, regulation, or other rule of law governing adoption, divorce, or other matters of family law; or (3) the Uniform Commercial Code, as in effect in any State, as specified. (15 U.S.C. §§ 7001, 7003(a).)
- Excludes from the application of E-SIGN the following specific transactions: (1) court orders or notices, or official court documents (including briefs, pleadings, and other writings) required to be executed in connection with court proceedings; (2) any notice of (A) the cancellation or termination of utility services (including water, heat, and power), (B) default, acceleration, repossession, foreclosure, or eviction, or the right to cure, under a credit agreement secured by, or a rental agreement for, a primary residence of an individual, (C) the cancellation or termination of health insurance or benefits or life insurance benefits (excluding annuities), or (D) recall of a product, or material failure of a product, that risks endangering health or safety; or (3) any document required to accompany any transportation or handling of hazardous materials, pesticides, or other toxic or dangerous materials. (15 U.S.C. § 7003(b).)
- Requires any person or entity that wishes to obtain medical information, as specified, to obtain a valid authorization for the release of this information. The release must be handwritten by the person who signs it or be in a typeface no smaller than 14-point type. It must be clearly separate from any other language present on the same page and be executed by a signature which serves no other purpose than to execute the authorization. It must be signed and dated by the patient or another legally authorized individual, as specified. The release must state a specific date after which the authority to disclose the medical information expires. (Civ. Code § 56.11.)
- Subjects a person who improperly discloses, as provided, genetic test results contained in an applicant’s or enrollee’s medical records without written authorization of the applicant to civil penalties, as specified. A valid written authorization must be written in plain language in typeface no smaller than 14-point type and be dated and signed by the individual or another authorized individual. It must further specify the length of the time the authorization remains valid. (Civ. Code § 56.17.)
- Provides that an authorization for an employer to disclose medical information shall be valid if it is handwritten by the person who signs it or is in a typeface no smaller than 14-point type; is clearly separate from any other language present on the same page and is executed by a signature that serves no purpose other than to execute the authorization; and is signed and dated by the patient or another legally authorized individual, as specified. The authorization must state a specific date after which the authority for the employer to disclose the medical information expires. (Civ. Code § 56.21.)
This bill:
- Deletes the exemptions for the above-described authorizations for release of medical information and genetic test results under the Confidentiality of Medical Information Act.
- Amends the requirement that such authorizations have a specific end date to allow for an “expiration event” to also suffice.
- Provides that an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement “end of the research study,” “none,” or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository.
COMMENTS
- Electronic transactions
In 1999 with the passage of SB 820 (Sher, Ch. 428, Stats. 1999), California enacted the Uniform Electronic Transactions Act (UETA), which was based on a model law to set rules by which electronic commerce may be conducted across the country proposed by the National Conference of Commissioners on Uniform State Laws. One of the motivating factors for enacting a law validating electronic records was the Statute of Frauds, which requires that certain contracts be in writing. In California, the Statute of Frauds is codified at Section 1624 of the Civil Code, which expressly states that certain contracts are invalid (i.e., unenforceable) unless they, or some note or memorandum thereof, are in writing and subscribed by the party to be charged or by the party’s agent. Such contracts include, for example: an agreement that by its terms is not to be performed within a year from its making; an agreement for a lease lasting for a period longer than one year; an agreement for the sale of real property, or of an interest therein; or specified contracts, promises, undertakings, or commitments to loan money or to grant or extend credit, in an amount greater than $100,000.
Subsequent to UETA’s passage, the Electronic Signatures in Global and National Commerce Act (E-SIGN) was enacted at the federal level. E-SIGN generally provides for the transmission of electronic signatures, but contains a number of exemptions. However, it does allow for vehicle sales to be conducted electronically.
UETA provides that a record or signature may not be denied legal effect or enforceability solely because it is in electronic form, that a contract may not be denied legal effect or enforceability solely because an electronic record was used in its formation, and that an electronic record or signature satisfies a requirement in the law that a record be in writing or a signature be affixed or if a law provides consequences if there is no record or signature.
UETA, however, does not apply to all contracts. For example, expressly excluded from UETA are: transactions that are subject to a law governing the creation and execution of wills, codicils, or testamentary trusts; specified transactions in the Uniform Commercial Code that were specifically drafted in consideration of electronic records; and transactions subject to a law that requires that specifically identifiable text or disclosures in a record or a portion of a record be separately signed or initialed, such as real estate transactions.
- Allowing for electronic signatures in connection with authorizations to release specified information
Relevant here, written authorizations for the release of medical information from a provider of health care, health care service plan, pharmaceutical company, contractor, or employer and for the release of genetic test results contained in an applicant’s or enrollee’s medical records by a health care service plan are exempt from UETA.
This bill removes these exemptions allowing patients to authorize the release of their medical information and genetic test results through electronically signing such authorizations.
Given the rise of telehealth services, especially in the wake of the COVID-19 pandemic, it is arguably appropriate to allow for such releases to be executed by electronic signature. Removing these exemptions removes a barrier for patients seeking to provide the relevant authorizations. However, there is concern that with the move to electronically signing such authorizations, patients will be less aware of what exactly they are authorizing. To mitigate any concerns in this area, the author has agreed to an amendment that requires copies of these authorizations to be provided to the signatories thereto.
According to the author:
AB 1697 will reduce administrative barriers patients face in authorizing medical providers to share their medical history. As transactions have increasingly occurred online, and as digital security has expanded to support legally binding electronic signatures, electronic signatures are becoming a secure and commonplace method of providing an individual’s legal authorization. With the advent of remote work and telehealth, allowing electronic signatures for medical release forms is an opportunity to reduce administrative barriers for patients. AB 1697 does so by ensuring that electronic signatures are given equal legal to physical signatures.
Writing in support, the California Dental Association states:
The use of telehealth services has significantly increased since the onset of the COVID-19 pandemic, which has included dentistry. As access to oral health through the use of teledentistry becomes more readily available, as in other areas of medicine, so should the availability of patient’s ability to use electronic signatures. Without updating existing law, patients may be able to receive critical and much needed care remotely, but then face barriers on the administrative side, having to either go in person or mail release forms back to their providers. AB 1697 will reduce administrative barriers for patients while continuing to protect patients through HIPAA.
- Relaxing the requirement for a specified end date
Currently, the above authorizations all require a specified end date upon which the authority to release records by the specified person or entity ends. For instance, Section 56.11 of the Civil Code provides that an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor must state a specific date after which the provider of health care, health care service plan, pharmaceutical company, or contractor is no longer authorized to disclose the medical information. Section 56.21 imposes a similar requirement for an authorization for an employer to disclose medical information. Section 56.17 provides for specified penalties for improper disclosure of genetic test results contained in an applicant’s or enrollee’s medical records by a health care service plan. Such disclosures must be made pursuant to a written authorization by the applicant that specifies the length of time the authorization shall remain valid.
This bill amends these requirements by alternatively allowing for specification of an “expiration event” to instead suffice. Such event must relate to the individual or the purpose of the use or disclosure. The statement “end of the research study,” “none,” or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository.
The ostensible goal appears to be to allow tailoring of authorizations to the purpose for which the information is being disclosed. For example, if medical information is being disclosed to determine whether one qualifies for a drug trial, it is arguably more efficient to allow the authorization to extend until one’s eligibility for the trial is determined or until the trial is complete, rather than an arbitrary period of time.
The purpose of the specified end date in current law is to protect the privacy of the signatories with respect to this incredibly sensitive personal information. The patient, enrollee, or applicant is also put on clear notice of how long the authorization will be in effect. However, allowing for such an expiration event severely weakens these protections as, by the plain language of the new provision, the authorization can exist in perpetuity. This could potentially allow the person or entity who gains authorization to access these medical records or genetic test results to request such information at any point into the future.
In order to provide some meaningful backstop against this outcome, the author has agreed to amendments that provide some outer temporal boundary for a stated expiration event. Pursuant to the amendments, an expiration event cannot extend beyond one year from the date of signing, except in the case of clinical trials or research studies. In the latter cases, the expiration event may extend longer than one year, but in no event can it extend beyond the end of the relevant clinical trial or study.
SUPPORT
California Dental Association
OPPOSITION
None known
RELATED LEGISLATION
Pending Legislation: None known.
Prior Legislation:
SB 1179 (Glazer, Ch. 39, Stats. 2022) amended UETA and allowed applications for Medicare supplement policies that are regulated by the California Department of Insurance to be signed electronically.
SB 361 (Umberg, 2021) would have authorized sellers of motor vehicles to offer buyers entering into a conditional sale or lease contract for the purchase or lease of a vehicle the option of signing their respective contracts electronically. The bill was later gutted and amended and died on the Assembly Inactive File.
AB 380 (Dababneh, 2017) See Comment 1.
AB 1743 (Dababneh, 2016) See Comment 1.
AB 1097 (Holden, Ch. 439, Stats. 2015) permits alarm companies, upon the consent of the contracting customer, to execute home solicitation contracts electronically, as specified, and allows for the execution of a notice of cancellation by electronic means pursuant to UETA.
AB 1131 (Dababneh, Ch. 638, Stats. 2015) amended the UETA to authorize an insurer, agent, broker, or any other person licensed by the Department of Insurance to send life insurance records by electronic transmission. This bill also allowed these licensees to send any written record by electronic transmission if not specifically excluded and if the licensee meets specified requirements.
SB 820 (Sher, Ch. 428, Stats. 1999) See Comment 1.
PRIOR VOTES:
Assembly Floor (Ayes 75, Noes 0)
Assembly Privacy and Consumer Protection Committee (Ayes 11, Noes 0)
**************
Date of Hearing: April 25, 2023
ASSEMBLY COMMITTEE ON PRIVACY AND CONSUMER PROTECTION
Jesse Gabriel, Chair
ABPCA Bill Id:AB 1697 (
Author:Schiavo) – As Amended Ver:April 6, 2023
Proposed Consent
SUBJECT: Uniform Electronic Transactions Act
SYNOPSIS
This author-sponsored measure would amend California’s Confidentiality of Medical Information Act and Uniform Electronic Transactions Act, so as to permit the use of electronic signatures to authorize the sharing of certain medical information. Under California law, these authorizations have long required handwritten signatures. The premise of this bill is that prohibiting e-signatures for these documents presents unnecessary obstacles for patients, given that telemedicine is increasingly the norm for provision of health care services in cases where in-person contact is unnecessary.
The bill also proposes to add further flexibility to authorizations for release of medical information, first, by allowing them to expire when a specified event occurs (rather than on a specified date), and second, by allowing non-electronic authorizations to be handwritten by persons other than the signatory (thereby assisting persons with certain disabilities.)
Committee amendments add appropriate safeguards, borrowed from federal law, for the use of expiration events, rather than expiration dates, on such authorizations.
The bill is supported by the California Dental Association. It has no opposition on file.
SUMMARY: Permits the use of electronic signatures to authorize disclosure of medical information and genetic test results. Permits these authorizations to expire on the occurrence of a specified event, rather than on a specified date. Allows persons other than the signatory to handwrite authorizations for release of medical information. Specifically, this bill:
- Deems an authorization for release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor to be valid if, among other enumerated requirements, the authorization:
- Is signed, even if signed with an electronic signature.
- States a specific expiration event, rather than a specific date, after which the authorized party is no longer authorized to disclose the medical information.
- Is handwritten, even if it is not handwritten by the person who signs it.
- Permits disclosure of genetic test results contained in an applicant’s or enrollee’s medical records by a health care service plan if, among other enumerated requirements, the written authorization:
- Is signed, even if signed with an electronic signature.
- Describes an expiration event, as an alternative to specifying the length of time the authorization shall remain valid.
- Deems an authorization for an employer to disclose medical information to be valid if, among other enumerated requirements, the authorization:
- Is signed, even if signed with an electronic signature.
- States a specific expiration event, rather than a specific date, after which the authorized party is no longer authorized to disclose the medical information.
- Is handwritten, even if it is not handwritten by the person who signs it.
- Amends California’s Uniform Electronic Transactions Act so that it no longer excludes a) electronic signatures for authorizations for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and b) authorizations for the release of genetic test results by a health care service plan, thereby authorizing the use of electronic contracts and electronic signatures for both.
EXISTING LAW:
- Provides, pursuant to the California Constitution, that all people have inalienable rights, including the right to pursue and obtain privacy. (Cal. Const., art. I, § 1.)
- Establishes the Confidentiality of Medical Information Act (CMIA) to regulate the sharing, sale, use for marketing, and other uses of medical information, as defined. (Civ. Code §§ 56-56.37.)
- Enumerates requirements for an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor to be deemed valid, including that the authorization:
- Be signed and dated by the patient or other statutorily-authorized person, such as the legal representative of the patient if the patient is a minor or an incompetent.
- State a specific date after which the authorized party is no longer authorized to disclose the medical information.
- Be handwritten by the person who signs it or in a typeface no smaller than 14-point type. (Civ. Code § 56.11.)
- Enumerates requirements for an authorization for the disclosure of genetic test results contained in an applicant’s or enrollee’s medical records by a health care service plan to be deemed valid, including that the authorization:
- Be signed and dated by the individual or other person authorized to act on the individual’s behalf.
- Specifies the length of time the authorization shall remain valid. (Civ. Code § 56.17.)
- Enumerates requirements for an authorization for an employer to disclose medical information to be deemed valid, including that the authorization:
- Be signed and dated by the patient or other statutorily-authorized person, including the legal representative of the patient, if the patient is a minor or an incompetent.
- State a specific date after which the authorized party is no longer authorized to disclose the medical information.
- Be handwritten by the person who signs it or in a typeface no smaller than 14-point type. (Civ. Code § 56.21.)
- Establishes the Uniform Electronic Transactions Act (UETA) to authorize the transaction of business, commerce, and contracts by electronic means. (Civ. Code §§ 1633.1–1633.17.)
- Exempts from UETA certain transactions that cannot be conducted using electronic records and signatures, including an authorization for the release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor and an authorization for the release of genetic test results by a health care service plan, both under the CMIA. (Civ. Code § 1633.3.)
- Clarifies that UETA does not require a record or signature to be created, generated, sent, communicated, received, stored, or otherwise processed or used by electronic means or in electronic form. (Civil Code § 1633.5(a).)
- Establishes under federal law, the Health Information Portability and Accountability Act of 1996 (HIPAA), which sets standards for the privacy of individually identifiable health information and security standards for the protection of electronic protected health information, including, through regulations, that a HIPAA-covered entity may not condition the provision of treatment, payment, enrollment in a health plan, or eligibility for benefits on the provision of an authorization, except under specified circumstances. Provides that if HIPAA’s provisions conflict with state law, the provision that is most protective of patient privacy prevails. (42 U.S.C. § 1320d, et seq.; 45 C.F.R. Part 164.)
- Provides that a valid authorization under HIPAA for use and disclosure of protected health information must include either an expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure. Permits the use of statement like “end of the research study” or “none” in connection with research. (45 C.F.R. § 164.508(c)(1)(v).)
FISCAL EFFECT: As currently in print this bill is keyed non-fiscal.
COMMENTS:
1) Background. California’s Uniform Electronic Transactions Act (UETA), enacted in 1999, generally recognizes that digital documents signed electronically have the same legal efficacy and validity as printed documents that are signed by hand. However, due to concerns around fraud and meaningful consent, certain documents and transactions are categorically excluded from UETA and must have a “wet ink” signature. Examples of such excluded documents and transactions are wills, automobile sales and lease contracts, and the subject of this bill: (i) authorizations for release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor; and (ii) authorizations for release of genetic test results by a health service plan. (See, generally, Civ. Code § 1633.3(b), (c).) California’s Confidentiality of Medical Information Act (CMIA) also imposes a handwritten signature requirement on both of these types of documents, as well as on authorizations for an employer to release medical information.
The premise of this bill is that California’s prohibition on e-signatures for these three categories of documents is unduly burdensome for patients, given that telemedicine is increasingly becoming the norm for provision of health care services where in-person contact is not required. Accordingly, the bill would permit e-signatures on all three categories of documents.
If enacted, this bill could prove relevant in implementing California’s Health and Human Services Data Exchange Framework, described as:
[A] first-ever, statewide data sharing agreement that will accelerate and expand the exchange of health information among health care entities, government agencies, and social service programs beginning in 2024. The data exchange framework is…an agreement across health and human services systems and providers to share information safely. That means every health care provider can access the information they need to treat you quickly and safely; health care, behavioral health and social services agencies can connect to each other to deliver what Californians need to be healthy; and our public health system can better assess how to address the needs of all communities. (Center for Data Insights and Innovations, What is the Data Exchange Framework?, available at https://www.cdii.ca.gov/committees-and-advisory-groups/data-exchange-framework/.)
The bill also proposes to add flexibility to authorizations for release of medical information by allowing them to expire when a specified event occurs (rather than on a specified date) and by allowing them to be handwritten by persons other than the signatory (thereby assisting persons with certain disabilities.)
2) Author’s statement. According to the author:
AB 1697 will reduce administrative barriers patients face in authorizing medical providers to share their medical history. As transactions have increasingly occurred online, and as digital security has expanded to support legally binding electronic signatures, electronic signatures are becoming a secure and commonplace method of providing an individual’s legal authorization. With the advent of remote work and telehealth, allowing electronic signatures for medical release forms is an opportunity to reduce administrative barriers for patients. AB 1697 does so by ensuring that electronic signatures are given equal legal [status as] physical signatures.
3) Analysis: permitting electronic signatures to authorize release of certain medical information. This bill would, for the first time, permit electronic signatures for three categories of documents: (i) authorizations for release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor; (ii) authorizations for release of genetic test results contained in medical records by a health service plan; and (iii) authorizations for disclosure of medical information by employers.
One justification for loosening these restrictions is that, increasingly, there are circumstances in which a person may want to consent to disclose such information, but for them to provide a handwritten signature may be unduly burdensome. For example, a patient who is consulting with a health care specialist for the first time likely wants the specialist to receive and review their medical records beforehand. But if this consultation takes place online, via telemedicine, the patient would have either had to travel to a location where they could provide a handwritten signature (a challenge for individuals with mobility impairments or without ready access to transportation), or provided the handwritten signature by mail (a challenge if the authorization needs to be provided quickly). The COVID-19 pandemic also made clear that it may be dangerous for a person to be in a health care facility unnecessarily, given they could either transmit or catch an illness while there. Permitting electronic signatures therefore also reduces the chances of unnecessary disease spread.
Generally speaking, there are two reasons that California law prohibits electronic signatures. The first is fraud. There are certain documents, such as wills and auto sales contracts, in which there might be financial incentives to affix a fake electronic signature to a doctored document. Authorizing the release of medical information does not seem to present the same sorts of financial incentives to commit fraud. Further, preparing a will and purchasing a car are events that occur relatively infrequently in most people’s lives. While obtaining a handwritten signature may be inconvenient, this inconvenience is offset by the fact that the signature needs to only be given rarely, and is given as part of a financially-significant transaction. By contrast, people frequently change employers and health insurers, and often see new medical providers. Given the unlikelihood of fraud in these circumstances, reducing the burdens attendant on sharing information under these circumstances seems worthwhile.
The second concern behind requiring handwritten signatures is to ensure that meaningful consent is given, under the assumption that a person will more closely review a paper document than a document presented on a screen, particularly a smartphone screen. If signing is conducted in-person, a handwritten signature requirement can also help ensure that the signatory is able to ask a human being to explain any confusing terms.
Federal law has permitted these classes of documents to be electronically signed in many other states since the late 1990s. Committee staff has reviewed case law involving electronically-signed medical release authorizations; they failed to find disputes in which a person asserted that they did not understand the nature of the document they were electronically signing. Given this absence, and for the reasons discussed above, it appears that California may reasonably permit these authorizations to be electronically signed.
Finally, it bears mention that nothing in UETA or in this bill would require a person to electronically sign an authorization to release their medical information. “UETA applies…only when the parties consent to conduct the transaction by electronic means.” (J.B.B. Investment Partners, Ltd. v. Fair (2014) 232 Cal. App. 4th 974, 988 [citing Civil Code Section 1633.5 (b)].) Preservation of the paper option is important, given that some individuals—due to age or disability—may face difficulty in filing electronic applications and/or lack devices to do so.
4) Analysis: allowing authorizations to lapse based on expiration events, rather than specific dates. This bill would also alter legal requirements for the three categories of documents discussed in the previous section—(i) authorizations for release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor; (ii) authorizations for release of genetic test results contained in medical records by a health service plan; and (iii) authorizations for disclosure of medical information by employers—by permitting the authorization to state a specific expiration event, rather than a specific date, after which the authorized party may no longer disclose the information in question.
The author’s goal appears to be to allow tailoring of authorizations to the purpose for which the information is being disclosed. If medical information is being disclosed, e.g., to determine whether one qualifies for a drug trial, it may make more sense to authorize disclosure until one’s eligibility for the trial is determined or until the trial is complete, rather than an arbitrary period of time.
Permitting a signer to specify an expiration event may also facilitate the goal of meaningful consent discussed above. It may be more likely that one understands one is signing an authorization for release of medical information if one has to specify an event that would terminate that authorization, rather than simply some future date.
One cause for concern, however, is that the bill offers no statutory guidance around what expiration events are, and are not, appropriate. It would be easy, under the current version of the bill, for someone preparing the authorization for signature to simply write “none” or “never” as the expiration event, and claim to have complied with the law.
5) Committee amendment—enacting appropriate safeguards for expiration events. A federal regulation, 45 C.F.R. § 164.508(c)(1)(v), places two safeguards around the use of expiration events in HIPAA-compliant authorizations for disclosure of medical information. First, the expiration event must “relate to the individual or the purpose of the use or disclosure.” That is, the expiration event must tie to the signer’s life circumstances or the reason the information is being disclosed. Second, provisions such as “end of the research study” or “none” are deemed appropriate in the context of research.
These standards appear to have proven workable in the more than two decades since they were first enacted at the federal level. Legal research again failed to uncover a dispute centering around defective specification of an expiration event. Accordingly, it appears prudent to import the federal standards into this bill, as follows:
Civil Code 56.11. […]
(j) For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement “end of the research study,” “none,” or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository.
Civil Code 56.17. […]
(j) For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement “end of the research study,” “none,” or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository.
Civil Code 56.21. […]
(j) For purposes of this section, an expiration event shall relate to the individual or the purpose of the use or disclosure. The statement “end of the research study,” “none,” or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository.
6) Analysis: allowing non-signatories to handwrite authorizations. California law currently permits handwritten authorizations to release medical information, but requires that the person signing the release be the same person who handwrote the authorization. (In certain circumstances, authorizations for release of medical information may be signed and dated by persons other than the patient, such as their legal representative or their spouse.)
This requirement is arguably burdensome for individuals who may have difficulty manipulating a pen or pencil due to age or disability.
To that end—assisting individuals facing such challenges—this bill would amend legal requirements for two of the categories of documents discussed above—(i) authorizations for release of medical information by a provider of health care, health care service plan, pharmaceutical company, or contractor; and (ii) authorizations for disclosure of medical information by employers—by deleting the requirement that such an authorization be handwritten “by the person who signs it.”
If a handwritten authorization allowed by this bill gives rise to a dispute, it may be helpful to know the identity of the person who wrote it in order to resolve the dispute. Committee staff briefly considered an amendment requiring a person who handwrites an authorization to also identify themselves as part of the written authorization. However, upon reflection, it became clear that a handwritten authorization is most likely to be used by a person in a relatively-informal setting (where an authorization form is not available); if the person writing the authorization did not know that they had to identify themselves, it would potentially invalidate the entire document. Also, in the event of a dispute, a person’s handwriting ought to produce significant forensic evidence as to their identity. Accordingly, Committee staff did not pursue this amendment.
7) Related legislation. SB 1020 (Johnston, Chap. 695, Stats. 1995) prohibited health insurers and health plans from providing different terms or benefits on the basis of genetic characteristics and established privacy protections for the results of genetic tests.
SB 820 (Sher, Chap. 428, Stats. 1999) enacted the Uniform Electronic Transactions Act (UETA) to authorize electronic signatures for many types of contracts, while exempting certain fraud-prone transactions such as conditional sale and lease contracts for motor vehicles.
SB 251 (Calderon, Chap. 369, Stats. 2013) authorized, until January 1, 2019, an insurer, with the consent of the policyholder, to transmit electronically certain notices pertaining to workers’ compensation insurance; the offer of renewal required for personal auto, real and personal property, and liability insurance policies; the notice of conditional renewal for commercial insurance policies; and the offer of renewal and certain disclosures related to earthquake insurance, so long as the insurer complied with UETA and certain additional procedures.
AB 2747 (Judiciary, Chap. 913, Stats. 2014), among other things, amended UETA to no longer exclude agreements for security deposits in residential rental housing.
AB 1743 (Dababneh, 2016) would have amended UETA to no longer exclude conditional sale and lease contracts for motor vehicles, while also enacting certain consumer protections. The bill died in the Senate Judiciary Committee.
AB 380 (Dababneh, 2017) was similar to AB 1743. The bill died in the Senate Judiciary Committee.
SB 1065 (Berman, Chap. 235, Stats. 2019) repealed the January 1, 2019 sunset date established by SB 251 (Calderon).
AB 133 (Budget, Chap. 143, Stats. 2021) established the California Health and Human Services Data Exchange Framework.
SB 361 (Umberg, 2021) would have amended UETA to no longer exclude conditional sale and lease contracts for motor vehicles, with no accompanying consumer protections. The bill died in the Assembly Judiciary Committee.
SB 1179 (Glazer, Chap. 39, Stats. 2022) authorized the use of electronic signatures on applications for Medicare Supplement Insurance policies regulated by the California Department of Insurance.
ARGUMENTS IN SUPPORT: California Dental Association believes this bill would facilitate teledentistry:
The use of telehealth services has significantly increased since the onset of the COVID-19 pandemic, which has included dentistry. As access to oral health through the use of teledentistry becomes more readily available, as in other areas of medicine, so should the availability of patient’s ability to use electronic signatures. Without updating existing law, patients may be able to receive critical and much needed care remotely, but then face barriers on the administrative side, having to either go in person or mail release forms back to their providers. AB 1697 will reduce administrative barriers for patients while continuing to protect patients through HIPAA.
REGISTERED SUPPORT / OPPOSITION:
Support
California Dental Association
Opposition
None on file
Analysis Prepared by: Jith Meganathan / P. & C.P. / (916) 319-2200
Discussed in Hearing
View Older HearingsBill Author
Bill Co-Author(s):